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ABSTRACT 
 
Effects of Lactobacillus rhamnosus MRS6AN on Intestinal GPAT3 Pathway Involved in the Lipid Transport 
in Enterocytes 
by 
Ayodeji O. Ipinmoroti 
Accumulation of triglyceride (TG) in enterocytes of the small intestine follows two specific 
absorption pathways: the monoacylglycerol acyltransferase pathway (MGAT) and glycerol acyltransferase 
pathway (GPAT), the latter (GPAT) is usually found in the small intestine. In this study, we investigated the 
effects of Lactobacillus rhamnosus MRS6AN, an isolate from “amabere amaruranu” a Kenyan traditional 
cultured milk, on triglyceride accumulation and expression of GPAT3, I-FABP, MTP and NPC1L1 in Caco-2 
cell enterocyte model. Intracellular triglyceride level (TG) of Caco2 cells was significantly reduced by live L. 
rhamnosus (LB) compared with other bacterial products. MTP expression in Caco2 cells was minimally 
reduced in live L. rhamnosus (LB) treated Caco2 cells. However, the expression level GPAT3, I-FABP and 
NPC1L1 was reduced in Caco2 cells treated with live bacteria. Data from this study suggests that 
Lactobacillus rhamnosus MRS6AN may reduce lipid uptake and accumulation perhaps via modulation of 
GPAT3 pathway. 
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CHAPTER 1 
BACKGROUND 
 Human survival depends on its environment and organisms with which it interacts (Chivian 2010) 
and its adaptability is slower compared to that of other smaller organisms, such as viruses and bacteria 
that are characterized by faster and more efficient rate of metabolism (Resta 2009), therefore for a more 
contestable adaptability and metabolism, human and other complex organisms have established symbiotic 
relationship as a mutual way to overcome metabolic and genetic related deficiencies (Gerritsen 2011). This 
mutual relationship which has systematically become a lifestyle has proven to be of long-term advantage 
and its being said that the community constituted by these complex organisms have become thehuman’s 
largest organ known as the gut microbiota (Resta, 2009) and (Gerritsen 2011). The concept of ingesting 
nonpathogenic and beneficial live microorganisms to improve the gastrointestinal health status and incur 
other health benefits has been traced to as far back as 20th century and ever since then until now it’s been 
a tireless effort trying to obtain and select effective strains good enough to be ‘probiotic’ (Maheshwari et 
al. 2012). Before 2001, no definition was really given to describe the term probiotics (Matur and Eraslan 
2012). The term “probiotics” was first introduced and defined in 1953 by Werner Kollath as microbial 
derived factors that stimulate the growth of other microorganisms (Maheshwari et al. 2012), in 1995 Roy 
fuller came up with his own definition of probiotics as a live feed supplement which beneficially affects the 
host, thereby improving its intestinal microbial homeostasis (Fuller et al. 1995). But as the quest towards 
the discovery of an alternative and more potent intestinal health breakthrough grew stronger, various 
governmental organizations agreed to work collectively in other to establish effective principles and 
guidelines for evaluation and selection of probiotics in food (Saran et al. 2011).  Probiotics in its long-term 
definition are live microorganisms including bacteria and yeasts which when ingested in adequate dosage 
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confers health benefits to the digestive system as well as gastrointestinal tract (Kechagia et al. 2013). The 
most commonly used and predominant genera are the Bifidobacterium and Lactobacillus (Cani et al. 2007). 
Probiotic potentials of these beneficial microorganisms depend largely on its reproducibility and stability 
which are important factors for survival within the gastrointestinal tract (Boyiri and Onyango 2014). Their 
sources are many; they are abundant in vegetables, dairy products, meats, human body, and pasteurized 
milk products among others. 
 
The GIT 
 The Human gastrointestinal tract known as the alimentary canal is a long tube of about 9 meters in 
length, with two opening ends at the mouth and the anus (Iqbal and Hussain 2009). The small intestine 
which is longest and the most complex part spanning about 7 meters in length and 2 to 3 meters in 
diameter is composed of various parts which include the mucosa, sub-mucosa, a single epithelium layer 
facing the lumen among others (Phan and Tso 2001). A large chunk of nutrient absorption takes place in 
the small intestine, this is due to its highly-differentiated structure (Iqbal and Hussain 2009). This structure 
could be understood by examining it in terms of crypt of Lieberkühn where constant regeneration and 
replacement of worn out intestinal cells occur (Iqbal and Hussain 2009). On the surface of intestinal wall 
are fingerlike protrusions known as villi, they are responsible for uptake of nutrients (Tso and Crissinger 
2000). The villi extend from the proximal region (made up of the duodenum and jejunum and are 
responsible for chyme absorption) to distal ileum where gastrointestinal hormones are released and bile 
salts recycled (Tso and Crissinger 2000). Another important part of the GIT is the apical region of the 
intestinal wall, a membrane where nutrients taken up by absorptive cells are metabolized and secreted 
across the basolateral membrane into the lymphatic vessel (Phan and Tso 2001). 
16 
 
Physiology of Enterocytes 
 Enterocytes are type of cells that absorb water and nutrients from the digestive tract. It is a 
columnar cell (tall and narrow in shape), with a "brush" border made of tiny protrusions called ‘microvillus’ 
which project into the space inside the gut (Stanfield 2016). Enterocytes originate inside intestinal glands, 
or crypts, in the small intestine and colon (Tso and Crissinger 2000). In the small intestine, enterocytes 
produce and secrete digestive enzymes, which bind to their brush borders and help break down sugars and 
proteins, making them smaller and easier to absorb (Tso and Crissinger 2000). Enterocytes in the large 
intestine absorb water and electrolytes (Shen Q X et al 2005). Most absorption of nutrients and digestion 
take place in the large intestine, the surface complexity in addition to other characteristics account for its 
unique adaptive features (Stanfield 2016) and (Tso and Crissinger 2000). 
 
Probiotics and Gastrointestinal Health 
One of gastrointestinal motility or the kinetics of its content is also an important variation in the 
maintenance of gastrointestinal homeostasis, and abnormality in motility can bring about discomfort 
varying from constipation to diarrhea (Kleessen et al. 1997). The interest in probiotics with respect to 
their motility regulatory roles is “making waves” in the treatment GI disorder (Huang et al 2004).  
Probiotics have been demonstrated to play a critical role in influencing gastrointestinal motility (Kleessen 
et al. 1997). Probiotic therapy of Lactobacillus acidophilus appear to significantly improve and restore 
impairment of interstitial cells of cajal caused by traumatic brain injury (TBI) (Sun 2015). Administration 
of L. acidophilus also improved contractile activities such as enhancement of smooth intestinal muscle 
movement, and prevention of MLCK dependent ML20 phosphorylation and MYPTI/MLCP dependent ML20 
phosphorylation inhibition by TBI (Sun 2015).  The idea of making use of these beneficial microorganisms 
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in modulating the microbial ecosystem (microbiome) from an abnormal or disease condition to a healthy 
state despite the present limited measure available for the treatment of gastrointestinal diseases is 
enticing. Studies have demonstrated the influence of probiotic isolates in the treatment of 
gastrointestinal diseases (Kleessen et al. 1997). The study involving the use of probiotics therapy 
conducted by Verdu et al. (2009) demonstrated the effect of L. rhamnosus R0011 and L. helveticus R0052 
on upper gastrointestinal tract dysfunction caused by protracted and chronic Helicobacter pylori 
infection. It was noted that mice infected with H. pylori for 4-6 months could not restore normal gastric 
functions even at 2 weeks-post eradication of H. pylori, but gastric functions soon became normal and 
regular after administration of L. rhamnosus and L. helveticus (Verdu et al. 2009). In addition, probiotics 
oral administration at 2-week post eradication of H. pylori restored normal feeding behavior (Verdu et al. 
2009). In support of the various evidences showing the inhibitory role of probiotics in gastrointestinal 
diseases, Marshall-Jones in 2006 concluded that probiotic consumption by healthy cats altered their 
gastrointestinal microflora by inhibiting the growth of Clostridium sp and Enterococcus faecalis (Marshall-
Jones 2006). Early research studies on probiotics were mainly based on the treatment of gastrointestinal 
disorders such as diarrhea (Kleessen et al. 1997). Probiotic inhibition of E. coli induced diarrhea has been 
shown to result when a combination of strains of L. gasseri, L. acidophilus and L. fermentum were 
isolated from healthy weaning pigs after 108cfu/ml of E. coli was orally administered. Huang and 
colleagues in 2004 concluded that diarrhea incidence was significantly decreased by reduction in E. coli 
count with a corresponding significant increase in the population of lactic acid bacteria (Lactobacilli) and 
anaerobes, indicating susceptibility of E. coli infection to presence of Lactobacilli sp (Huang et al. 2004). 
Meta-analysis of various clinical trials and procedures involving treatment of diarrhea using rehydration 
therapy has proven the use probiotics to be a potent measure for the treatment of diarrhea patients 
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(Oberhelman et al. 1999). For example, stool consistency can be improved through feeding on 
Bifidobacterium cultured milk, a laxative effect that requires large masses of the probiotic genera 
(Ishibashi et al. 1996).  Some Bifidobacteria strains have been demonstrated to possess anticarcinogenic, 
antimutagenic and antitumorigenic properties (Nagpal 2012). Some studies involving the use of 
laboratory animals have buttressed the influence of probiotic genera like Lactobacilli and Bifidobacterium 
on the suppression of tumorigenesis. In a study conducted in 1993, it was shown that strains of B. 
longnum suppressed azomethane-induced colon carcinogenesis in rats (Reddy and Rivenson 1993). 
Another study carried out by Singh and colleagues documented that this same species of Bifidobacterium 
also reduced carcinogenesis caused by food mutagen, 2-amino-3-methylimidazo[4,5-f] quinoline (Singh 
et al. 1997). 
 
Probiotic Role in Immune Functions 
Certain strains of Bifidobacterium and Lactobacilli within the human GIT induce enhanced immune 
function by stimulating both innate and adaptive immune system as well as activation of specific 
antibodies to invading pathogens (Valeur et al. 2004). Although this has been demonstrated mainly in mice 
models, human studies are now been carried out to justify claims. Certain strain of Lactobacilli has been 
shown to increase secretory IgA level and activation of rotavirus specific antibodies when ingested 
(Phuapradit et al. 1999). These gut-associated microorganisms interact with a variety of cells involved in 
immune responses; T lymphocytes, T-helper and regulatory cells, dendritic cells among others where they 
modulate anti-inflammatory immune responses, gut development and integrity (Mercola 2008) and 
(Galdeano et al. 2008). According to Perdigon et al. (1995), probiotics selected for their ability to influence 
immune responses via immunomodulatory and immunoregulatory pathway could stimulate cytokine 
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expression and significantly reduce the level of serum C-reactive proteins (CRP) (Perdigon et al. 1995). 
Probiotic Lactobacillus reuteri orally administered could increase immune cell population such as CD4 
positive cells (Valeur et al. 2004). Biopsy samples from stomach, duodenum and ileum obtained from 9 
healthy human subjects has shown the colonization of the gastrointestinal tract by endogenous L. reuteri 
which led to an increase in the population of CD-positive T-Lymphocytes in the ileal epithelium (Valeur et 
al. 2004). Invitro study of the probiotic influence of Enterococcus faecium on immune cell recruitment and 
epithelia integrity revealed that porcine and human intestinal cells (Caco-2) exhibit low trans-epithelial 
resistance, increased mRNA level and protein expression of IL-8 when predisposed to enteropathogenic E. 
coli (EPEC) and enterotoxigenic E. coli (ETEC). However, reduced trans-epithelial resistance was inhibited 
and decreased proinflammatory stress cell responses were observed when EHEC and or ETEC were co-
incubated with E. faecium (Shanti 2014).  
Another immune system related function exerted by probiotics include ability to reverse the state 
of metabolic dysbiosis and restoration and maintenance of immune homeostasis (Schriffin & Blum 2002).  
Probiotic strains Lactobacillus casei and Lactobacillus rhamnsosus GG have been demonstrated to express 
certain surface exopolysaccharides and surface glycoproteins which interact with different immune 
sensors such as TLRs and NODs expressed on the surface of intestinal epithelia. These structures recognize 
certain molecular associated molecular patterns (MAMPs). This interaction may induce a signaling cascade 
that initiates innate immune responses, such as expression of anti-microbial factors, antigen presentation, 
pro and anti- inflammatory cytokine production (Claes et al. 2012) and (Baarlen et al. 2013). 
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Lipid Absorption in Enterocytes 
Western diet lipids are primarily made up of phospholipids, free cholesterol, triglycerides which 
eventually constitute 90% of overall dietary lipid consumed. (Tso and Crissinger 2000). 
An important phase of fat digestion and absorption is bile salt which emulsify the fats allowing them to 
form solution as micelles in chyme, and so increase the surface area on which the pancreatic lipases can 
operate (Figure 1). Micelles are small, and because they have the hydrophilic side externally, they 
effectively allow the fats to act like water soluble particles. This allows them to penetrate the unstirred 
water layer adjacent to the small intestine epithelium which represents an important barrier for lipid 
uptake by enterocytes (Tso and Crissinger 2000). In the absence of bile salts, a biological detergent that 
allows the formation of mixed micellar structure with lipolysis products, very few fatty acids make it 
through this unstirred water layer and much of the fat will pass through the gut undigested and 
unabsorbed causing steatorrhea (fatty stool) (Arthur and Guyton 1975). Bile salts significantly increase the 
resulting lipid product’s concentration which is close to the brush border membrane for effective 
absorption (Tso and Crissinger 2000) and (Tso et al. 2004). The micelles enable the fatty acids and 
cholesterol to cross the unstirred layer and get in contact with the brush border, where they easily cross 
the fat-soluble cell membrane. A few smaller free fatty acids transfuse across the cell and out at the baso-
lateral border, passing into the capillaries. However most fatty acids enter the smooth endoplasmic 
reticulum where they are repackaged into chylomicrons. These are excreted off the cell by exocytosis 
(Shen Q X et al. 2005). 
Digestion and absorption of dietary lipid and other nutrients take place within the first 20% of the 
small intestinal region. Several enzymes associated with dietary lipid uptake and re- esterification are 
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dominantly expressed, especially, in the mid-region of the small intestine where lipid absorption takes 
place (Cao et al. 2004) and (Storch et al. 2010). 
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 Figure 1. Dietary lipid absorption pathway showing lipid transport in enterocyte. 
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TAG Synthesis 
Dietary lipids are either absorbed as free fatty acids (FA) and sn-2 monoacylglycerol (sn-2-MG) 
esterified by monoglycerol-acyltransferase (Ahn 2010) or as esterified sn-1 glycerol phosphate and fatty 
acyl-CoA by glycerol phosphate-acyltransferase (Shan et al. 2010). Two pathways had been reportedly 
involved in the re-esterification of triglycerides, the glycerol-3-phosphate acyltransferase pathway and the 
monoacylglycerol acyltransferase (MGAT) pathway (Figure 2). Nevertheless, synthesis of TG in the small 
intestine is primarily through the MGAT pathway (Tso and Crissinger 2000).  The present study will focus 
mainly on the expression five predominant proteins and transporters that have been known to play a 
critical role in lipid uptake and accumulation by intestinal cells. A recently characterized GPAT3 has been 
also shown to be involved in maintaining lipid homeostasis in the gastrointestinal tract (Khatun et al. 
2015). 
Khatun et al. (2015) investigated the role of a novel intestinal glycerol-3-phoshate acyltransferase 
pathway in dietary lipid homeostasis within the small intestine. Previous studies have documented a vital 
role played by GPAT3 in the synthesis of TAG in adipocytes (Cao 2006). GPAT3 has also been found to be 
abundantly expressed and readily detectable in the small intestine especially in the jejunum (Khatun et al. 
2015). When dietary triglycerides are absorbed by enterocytes they undergo luminal hydrolysis into 
monoglycerides and fatty acids after which they are secreted as chylomicrons which transport then 
through lymphatic vessels of the lamina propria of the basolateral surface of the enterocyte (Hussain 
2014). This process is carried out through two main routes namely Glycerol-3-phosphate and 
Monoacylglycerol pathway, G3P is acylated by a member of G3P acyltransferase and is further acylated 
and dephosphorylated to produce diacylglyerol (Kennedy and Weiss 1956). Khatun et al. (2015) reported 
that GPAT3 was abundantly expressed in the apical surface of enterocytes of small intestine, and that 
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GPAT3 knockout mice exhibited lipid accumulation in enterocytes and they displayed modest elevation in 
the level of enteric FFA (Khatun et al. 2015). Although detail analysis of subcellular localization of GPAT3 
expression was hypothesized, its targeted disruption was however found to result in dysregulation of TG 
secretion from the small intestine (Shan et al. 2010).  Understanding the rudiments guiding the absorption 
of nutrients and handling of dietary lipids in the gastrointestinal tract is the target of much of the ongoing 
research. This present study is designed to investigate the effects of Lactobacillus rhamnosus, a probiotic 
isolate from a Kenyan locally cultured milk product on the expression of genes involved in lipid 
homeostasis in enterocytes. 
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Figure 2. Biochemical pathway of lipid metabolism via Glycerol-3-phosphate (G3P) and Monoacylglycerol 
(MG) pathway 
 
Glycerol-3-Phosphate Acyltransferase (GPAT3) 
GPAT catalyzes the first step in the de novo synthesis of glycerolipids (Shan et al. 2010) involving 
the esterification of Glycerol-phosphate and Fatty acyl-CoA at the sn-1 position a reaction that is catalyzed 
by GPAT to produce lysophosphatidic acid, a precursor for the synthesis of triacylglycerol and 
phospholipids (Dircks and Sul 1999) and (Coleman and Mashek 2011). Esterified product of monoglyceride 
(sn-2 MG) act as an inhibitor to the synthesis of glycerol-phosphate (Phan and Tso 2001) and it is therefore 
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believed that 80% of TG re-esterified and re-synthesized occur through the MGAT pathway. Four 
mitochondrion associated isoforms of GPAT have been characterized in mammals based on their 
sensitivity and resistivity to sulfhydryl group modifying reagent N-ethylamide. The NEM resistant isoforms 
are commonly found in the mitochondria of liver cells while sensitive isoforms are ER-bound (Shan et al. 
2010) which account for most GPAT activities in most tissues (Yet et al. 1995). The first two isomers GPAT1 
and GPAT2 belong to the same subfamily on the phylogenetic classification and these mitochondria 
associated isoforms do not share significant homology with the microsomal GPAT3 and GPAT4 (Shan et al. 
2010). Although GPAT3 has been reported to be relatively low in human and mouse liver, and that it is 
more expressed in the adipose tissue. Shan et al. (2010) concluded that more copies of GPAT3 are 
expressed in the small intestine of mouse than GPAT4 whose mRNA abundance is found in the brown 
adipose tissue. Murine gpat3 gene had been found to be abundantly expressed in the heart, adipose tissue 
and the small intestine where it is majorly localized in the jejunum microsomal masses, a predominant site 
for TG absorption (Khatun et al. 2015). Khatun et al. (2015) experimental studies revealed that there was a 
significant decrease in GPAT activities in the jejunum of GPAT3 knock-out mice. This result indicates that 
GPAT3 is responsible for the abundant GPAT activities in the jejunum of mice. 
 
Niemann Pick C1-Like1 (NPC1L1) 
One of the most critical proteins involved in the uptake of lipids by enterocytes is the NPC1L1, it is a 
homolog of Niemann-Pick C1 protein which when mutated results in a genetic disorder expressed as 
accumulation of cholesterol in the lysosome (Carstea et al. 1997) and (Loftus et al. 1997). This protein is 
overly expressed in the small intestine, mostly on the surface of enterocytes (Altmann et al. 2004) and it’s 
abundant at the apical surface of the absorptive enterocytes (Davies et al. 2005) and (Sane et al. 2006). 
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Niemann-Pick Cell 1 like 1 (NPC1L1) has been shown to be predominantly expressed in tissues such as the 
liver, small intestine, lung, kidney, heart and pancreas (Davies et al. 2005). Although NPC1L1 expression is 
abundant in both human liver and small intestine, studies using liver-derived HepG2 cells and Caco2 cells 
as models have revealed that human NPC1L1 is overly expressed in the human liver than in the small 
intestine respectively (Davies et al. 2005). In terms of localization in the small intestine, Christiaan and 
colleagues in 2010 concluded that NPC1L1 is highly expressed in the jejunal region of the small intestine 
than other regions. Its expression in the ileum is higher compared with that of the duodenum. NPC1L1 is 
primarily localized in the endocytic recycling compartment but it migrates to the plasma membrane when 
cells are deprived of cholesterol (Lin et al. 2011). Consequently, mutation or attenuation of NPC1L1 in mice 
led to significant reduction in intestinal cholesterol (Altmann et al. 2004). Cholesterol is incorporated into 
micelles containing bile acid, fatty acid and monoglyceride. This helps it to diffuse through the unstirred 
water layer which is the major barrier between the outer and the brush border membrane and is 
eventually transported by NPC1L1 into the cell. Evaluation of the plasma lipid level and cholesterol level in 
NPC1L1 knockout mice revealed observable reduction in the plasma lipid level as well as LDL cholesterol 
compared to the wild type (Davies et al. 2005), this result indicates the importance of NPC1L1 in the 
process of cholesterol absorption (Davies et al. 2005). 
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Intestinal Fatty Acid Binding Protein (I-FABP) 
This is one of three subfamilies already discovered and characterized in enterocytes, they are the 
cytosolic proteins responsible for the processing of products derived from the hydrolysis of TG. Intestinal 
fatty acid binding protein (I-FABP) is predominantly expressed in enterocytes of mammals and has been 
suggested to be involved in the absorption of fatty acids from the lumen into the cell (Alpers et al. 2000). 
Three isoforms FABP1, FABP 2 and FABP 6 studied by Esteeve and his team in 2015 exhibits varying 
localizations in the small intestine. FABP1 and FABP 2 were highly expressed in about 70% of proximal 
small intestine and distal jejunum (Agellon et al. 2002). Studies have also confirmed that human FABP1 has 
high affinity for short-chain and medium-chain fatty acids (Esteeve et al. 2016) by participating in cellular 
absorption and transport of unesterified fatty acids and metabolism of dietary lipids (Montoudis et al. 
2008), (Storch and Thumser 2010) and (Lagakos et al. 2011). Investigations have shown that other isoforms 
of FABP present in the small intestine also take part in dietary lipid uptake irrespective of I-FABP 
expression. Furuhashi and Gökhan in 2008 demonstrated that male I-FABP knock out mice gained more 
weight and acquired larger liver mass after their feeding period. They therefore suggested that fatty acid 
uptake might have been mediated by other members of FABP expressed in the small intestine and the 
liver. Overexpression of I-FABP results into a decrease in the incorporation of free cholesterol by causing a 
significant reduction in the gene expression level of cholesterol transporter NPC1L1 (Motoundis et al. 
2008). 
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Fatty Acid Transfer Protein (FATP4) 
This is a major type of fatty acid transport protein found in the small intestinal enterocytes, it is a 
functional fatty acid transporter that belongs to the family of VLC acyl-CoA synthetase and it responsible 
for the uptake of long-chain and VLC fatty acid (Gimeno et al. 2003) and acylation of VLCFA, and are 
localized in the subapical brush border membrane facing the lumen of the small intestine and in the 
endoplasmic reticulum. FATP4 is the only FABP expressed in the small intestine, with highest expression in 
the proximal duodenum and jejunum than in the distal part of the small intestine (Nassir et al. 2007). It 
also predominantly co-exists with FATP1 in the brain (Fitscher et al. 1998). However, FATP4 mRNA is not 
evident in other small intestinal cells like the smooth muscle, mesenchymal and endothelial cells (Trumpp 
et al. 1999) and the protein level are highly expressed in differentiated enterocytes but little or no 
expression is observable in the crypt where there is high rate of metabolism. FATP4 does not only function 
as a transporter, it may also play very critical role in the metabolism of very long chain fatty acid (VLCFA). 
Invitro studies have suggested that other transporters may have the same role as FATP4, rendering it 
dispensable. Shim and team in 2009 investigated the physiological role of FATP4 in lipid uptake using 
transgenic mice, there was reportedly no significant compensatory increase in expression of other 
members of FATP in FATP4 knockout mice, suggesting that it plays an expendable role in intestinal dietary 
lipid absorption (Shim et al. 2009). On the contrary, targeted deletion of FATP4 lead to 40% reduction of 
fatty acid absorption by intestinal enterocytes. In vivo analysis of consequential effect of low FATP4 
expression level on lipid absorption revealed that mice carrying a deletion allele of FATP4 caused a 
decrease in LCFA uptake by enterocytes but did not affect the overall in vivo lipid absorption compared to 
the wild type (Gimeno et al. 2003). 
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Microsomal Transport Protein (MTP) 
Microsomal transfer protein or microsomal triglyceride transfer protein is an endoplasmic 
reticulum lumenal protein that is responsible for the assembly and secretion of chylomicrons rich in 
triacylglycerol and VLDL lipoprotein in the liver and small intestine (Jamil et al. 1995) and (Iqbal et al. 
2014). This evidence was first documented by Wetterau and Zilversmit in 1984, when they isolated and 
purified MTP. Secretion of chylomicrons depend on MTP and an indispensable Apolipoprotein-B (ApoB), 
and they physically engage in a protein-protein interaction during lipoprotein biogenesis (Hussain et al. 
2003). Immunoprecipitation of HepG2 cells with anti-apoB and anti-MTP resulted in precipitation of apoB 
by anti-MTP and its subunit antibodies suggesting the interaction between the two proteins (Wu et al. 
1996). MTP may harbor three functionally independent domains for binding, associating and transfer of 
lipid (Hussain et al. 2003). MTP’s ability to efficiently transport lipids depends on acylation of TAG products 
and the readiness of the lipid masses to bind MTP which supports it preferential specificity for binding and 
transporting nonpolar lipid (Jamil et al. 1995). MTP transfer of lipid was studied with a model membrane 
(Atzel et al. 1993). It was revealed in the study that MTP molecules use their binding domains to 
momentarily interact with the membrane by extracting the lipid, detaching and delivering the lipid to a 
second membrane by rapidly binding to it and continuing to a next cycle (Atzel et al. 1993). 
 
Influence of Probiotics on Gastrointestinal Lipid Profile 
There is evidence that the relationship that exists between alteration of intestinal microflora utility 
and/or composition and metabolic dysfunction may be related to the cause of some cardiovascular 
diseases such atherosclerosis and low-grade chronic inflammation, a principal factor in the onset of 
obesity related metabolic instabilities (Kobyliak et al. 2016). 
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Recent studies have established that one of the several roles played by probiotics include the 
protective effect against patho-physiological alteration associated with excess accumulation of fat within 
the body (Aronsson et al. 2010). Several underlying mechanisms have been attributed to the lipid lowering 
potential of several probiotic bacteria strains enabling them to modulate energy harvest, inflammation 
and lipid metabolism genes and their enzymatic activities (Delzenne et al. 2011). Yoo et al. (2013) 
demonstrated that some Lactobacilli strains; L. curvatus and L. plantarum reduced fat accumulation in 
both the liver and the adipose tissue. Fat accumulation within the GIT, liver and the heart has been known 
to be associated with dysregulation of lipid and glucose in a study that was carried out using germ free 
mice (Yoo et al. 2013). A link between obesity and gut microbiota was unveiled when metagenomic 
sequencing of obese and lean mice showed different gut microbiome (Ley et al. 2006). 
Animal studies carried out by Yoo et al. in 2013 suggested that administration of probiotics could 
reduce in sizeable amount the weight gained because of excess high fat diet intake. Feed supplemented 
with Lactobacillus curvatus HY7601 or combination of Lactobacillus curvatus HY7601 and L. plantarum 
KY1032 effectively reduced total adipose tissue weight in mice fed with high fat diet for 9 weeks.  Similarly, 
a recent study had reported that a 12-week high fat diet supplemented with either L. paracasei CNCMI-
4270, L. rhamnosus I-3690 or Bifidobacterium animalis subsp. lactis I-2494 significantly suppressed HFD-
induced overweight irrespective of reduction in food intake in mice. The use of three strains of 
Lactobacillus plantarum CECT 7527, 7528 and 7529 by Montserrat and his team in 2013 to reduce the level 
of cholesterol in the small intestine of pig demonstrated that the probiotic strains could reduce cholesterol 
level in the lower gastrointestinal tract by secretion of large quantity of propionic acid and butyric acid. 
Another mechanism of cholesterol reduction is by binding and adherence of cholesterol to bacterial 
cellular surface (Montserrat et al. 2014). 
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A double-blind, randomized and placebo-controlled trial conducted to evaluate the impact of 
perinatal probiotic administration and intervention on childhood gut and overweight development 
following a 10 year sequel, showed that administration of Lactobacillus gasseri SBT2055 containing 
fermented milk for a period of 48 days resulted in a significantly reduced abdominal visceral and 
subcutaneous fat accumulation by 4.6% and 3.3% respectively, leading to a 1.5% total reduction in body 
mass index (BMI)  (Kobyliak et al. 2016). This demonstrates that L. gasseri has a beneficial impact on the 
GIT metabolic disorder. 
Cardiovascular diseases (such as atherosclerosis and other health disorder like coronary heart 
disease), liver cirrhosis, dyslipidemia and type-2 diabetes, have been traced back to hypercholesterolemia 
(Das and Mukhopadhyay 2011). Although no clear relationship has been established between obesity and 
type-2 diabetes, nonetheless, obesity has been shown to increase the risk of acquiring insulin resistance 
which is a principal cause of type 2 diabetes (Das and Mukhopadhyay 2011). Probiotic isolates could be 
used in the improvement and control of insulin resistance and enhancement of the lipid profile leading to 
prevention of NAFLD (non-alcoholic fatty liver disease, a chronic liver disorder. Kim and his team in 2013 
demonstrated this by conducting a 13-week study involving the use of L. rhamnosus GG to improve the 
insulin sensitivity and lipid accumulation in high fat diet (HFD) fed mice (Kim et al. 2013). This study was 
reiterated by Tabuchi and colleagues in 2003, when they showed that Lactobacillus rhamnosus GG could 
decrease glycated hemoglobin and reduced glucose intolerance streptozocotin-induced diabetic mice 
leading to a sizeable increase in insulin secretion (Tabuchi et al. 2003). Comparably, Lactobacillus 
rhamnosus GG administration to high fructose diet induced NAFLD prone mice resulted in gut barrier 
restoration and inhibition of liver steatosis and development of inflammation in mice (Ritze et al. 2014). 
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The absorption of dietary lipids and reabsorption of biliary cholesterol in the jejunum, lumen and 
duodenum contribute to the regulation of plasma cholesterol level. In other words, reduction in 
absorption of dietary lipid in the small intestine helps to decrease plasma cholesterol level (Liong and Shah 
2005). Ever since Mann and Spoerry in 1974 discovered the hypocholesterolemic effects of fermented milk 
taken by the people of Massai tribes, the relationship between lactic acid bacteria and cholesterol 
absorption has become a study of great focus and interest. Several hypotheses have been proposed to 
demonstrate this relationship. It’s believed that the consumption of dietary lipids in the intestine by some 
intestinal bacteria reduces the level of cholesterol available for absorption (Pigeon et al. 2002) and (Pereira 
et al. 2002). The role of a novel probiotic isolate on intestinal absorption of lipids by enterocytes is the 
subject of the present study. Caco-2 cell culture model will be used in this study. Caco-2 cell line is a 
continuous cell of heterogeneous human epithelial colorectal adenocarcinoma cells, developed by 
the Sloan Kettering Institute for Cancer Research through research conducted by Dr. Jorgen Fogh 
(Awortwe 2014). Though it was derived from a colon (large intestine) carcinoma, when cultured under 
specific conditions the cells become differentiated and polarized such that their phenotype, 
morphologically and functionally, resembles the enterocytes lining the small intestine.  
Various protein and enzymatic activities have been investigated, some of which are known to be 
involved in the regulation of lipid metabolism in the GIT. Huang and Zheng in 2009 showed that NPC1L1 
(Niemann-Pick C1-like 1) expression can be decreased by specific strains of L. acidophilus and L. rhamnosus 
GG. These strains were better inhibitors of NPC1L1 than other strains tested. Brown and Yu (2009) have 
also demonstrated the role of heterodimers of ATP-Binding Cassette transporters ABCG5 and ABCG8 in the 
intestinal disposal of sterols. Moreover, two probiotic strains of Lactobacilli which include Lactobacillus 
plantarum NR74 and Lactobacillus rhamnosus BFE5264 isolated from Massai fermented milk (Marthara et 
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al. 2008) and Korean Kimchi (Lee et al. 2011) and their probiotics potential have been studied in vitro. 
These bacteria stimulate the up-regulation of liver X receptor (LXR) also known as nuclear receptor (NR) 
which controls some transcriptional factors related to lipid metabolism and down-regulate a number of 
genes involved in cholesterol absorption, efflux, transport and eventually excretion (Yoon et al. 2012). This 
they do by enhancing the expression of heterodimer of LXR which are LXRα and LXRβ in Caco2 cells (Yoon 
et al. 2012). 
 
Choice of Lactobacillus rhamnosus MRS6AN 
Among the various isolates characterized by Boyiri and Onyango in 2015, Lactobacillus rhamnosus 
MRS6AN was found to exhibit greater probiotic potential, in that it does not degrade mucin (Boyiri and 
Onyango 2015), a glycoprotein of the mucus layer produced by epithelia cells (Boskey 2013). It was 
isolated from a traditionally cultured Kenyan milk called “Amabere Amaruranu” alongside other isolates 
belonging to the same genus and Acetobacter. Lactobacillus. rhamnosus MRS6AN was characterized using 
16sRNA. Lactobacillus rhamnosus MRS6AN also demonstrated stability in extreme harsh and unfavorable 
conditions such as bile salt and acidic conditions (Boyiri and Onyango 2015). In terms of antimicrobial 
activities, they inhibited the growth of other bacterial test strains (Boyiri and Onyango 2015).   
Nevertheless, no data or evidence has been documented regarding the role of L. rhamnosus MRS6AN on 
intestinal lipid absorption and TG accumulation. Hence, this present study is focused on the influence of L. 
rhamnosus MRS6AN on intestinal lipid absorption and accumulation in enterocyte, and its consequential 
effect on GPAT3 mediated pathway, fatty acid binding protein (FABP) and microsomal transport protein 
(MTP).   
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Hypothesis  
L. rhamnosus MRS6AN will modulate absorption of lipids by regulating the expression glycerol-3-
phosphate acyltranferase (GPAT3) and the expression of genes involved in GPAT3 pathway.  
 
Objectives 
  Firstly, to determine and quantify cellular lipid uptake by Caco2 cells when co-culture with Lactobacillus 
rhamnosus MRS6AN, heat inactivated MRS6AN, its cell extract or its filtered spent broth. 
Secondly, to determine the expression level of GPAT3 enzyme, MTP, I-FABP involved in lipid absorption via 
GPAT3 pathway and a sterol transporter NPC1L1 in Caco2 cells when co-cultured with L. rhamnosus 
MRS6AN, heat inactivated MRS6AN, its cell extract or its filtered spent broth. 
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CHAPTER 2 
 
MATERIALS AND METHODS 
Isolation of Lactobacillus rhamnosus and Preparation of Probiotic Cell Extract 
           Identification and isolation of L. rhamnosus MRS6AN from a Kenyan locally cultured milk (amabere 
amaruranu) was previously carried out using biochemical testing and 16S rRNA sequencing and they 
demonstrated optimum probiotic characteristics compared to other isolates in its stability in the presence 
of acid and bile salt and its inability to degrade mucin. Other isolates characterized include L. paracasei, L. 
casei, L. reuteri, L. acidophilus and Acetobacter sp. The isolate was cryo-preserved at -800C with storage 
beads (Boyiri et al. 2015). 
 
Growth Media for Bacteria 
Oxoid DeMann Rogosa Sharpe Media (CAT No. CMO359) was supplied by Thermo scientific. 
 
Human Adenocarcinoma Cell (Caco2 cells) 
            Human colon derived Caco2 cells are fast growing cells, they begin to exhibit characteristics similar 
to those of enterocytes lining the wall of the small intestine after they have attained 21 days post 
confluence demonstrating a differentiated monolayer (Olejnik 2003) and developing tight junctions for 
regulation of permeability of molecules and ions (Assimakopoulos et al. 2011). 
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Human Colon Derived Caco-2 Cell Culture Media 
          Dulbeco’s Modified Eagle’s Media (DMEM) supplemented with 10% fetal bovine serum (Hyclone, Cat 
No. SH30088.03, supplied by GE Lifecare Healthsciences, Logan Utah, 84321), 5% Penicillin-streptomycin 
(Corning cellgro, Meditech, Inc. Mannasas, VA 20109) and 5% Sodium-pyruvate was used to culture Caco2 
cells (Hyclone, Cat No. SH30239.01, supplied by Thermo Fischer Scientific). 
 
Primary and Secondary Antibodies 
          Mouse anti-human I-FABP (E-9, Cat No: sc-374482), MTP 110 (2G2, Cat No: sc-58807) and ACSVL4 (H-
6, Cat No: sc-393309) were obtained from Santacruz Biotechnology and GPAT3 (Cat No: AP18013c) was 
obtained from VWR. The antibodies were used in western blot protein assay for FABP, MTP, FATP4 and 
GPAT3 respectively. Secondary anti-mouse M-IgG-kappa BP-HRP (Cruz marker, Cat No: sc-516102-CM) was 
obtained from Santacruz Biotechnology for the detection assay. 
 
Lactobacillus rhamnosus MRS6AN Culture 
Lactobacillus rhamnosus was cultured, until an early stationary phase of growth, in nutrient rich 
MRS broth media under anaerobic conditions at 37 oC overnight. The optical density was monitored at 600 
nm (OD600) until it attained an optical density of 2.0. Pure culture of bacteria was verified using MRS agar 
media. Bacterial cells were centrifuged at 3000 g for 5 mins at 6 oC. The supernatant was decanted. 
Bacteria pellets were washed in PBS pH 7.2 and re-suspended in DMEM media (107 cfu/ml) at the time set 
for co-culture. 
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Preparing Probiotic Cell Extracts 
A seed culture was prepared by inoculating a storage bead stored at -80 0C in a test tube containing 
5 ml DeMan-Rogosa-Sharpe broth (MRS) and incubated for 18hrs at 37oC. Ten to fifteen drops of seed 
culture were subculture into a 250 ml flask containing 100 ml MRS broth and incubate on shaker for 24 
hrs. at 37 0C. Optical density reading was monitored at 600 nm (OD600) until it reached 2.0. Ten milliliters 
(10 ml) of bacteria culture was dispensed into 50 ml centrifuge tube and centrifuged at 14000 rpm or 1100 
g for 15 minutes. The supernatant was collected as the spent broth from the live bacteria (LB) by decanting 
into a 50 ml cork screw flask and the resulting pellets were washed twice in PBS pH 7.4. (The pH of the 
spent broth was low due to production of lactic acid by bacteria, but was raised to 7.4 using NaOH). The 
spent broth was filtered with 0.22 µm Millipore filter to collect the Filtered spent broth (FSB). 
Bacteria pellets were re-suspended in 50 ml PBS, and the suspension was sonicated 5 times at 44 % 
amplitude for 2 minutes each at 6 minutes interval of rest. The sonicated suspension was centrifuged at 
1100 g for 15 minutes at 4 0C. The resulting supernatant was collected and filtered through 0.22 µm 
Millipore filter to obtain the cytoplasmic fraction (CF). Live bacteria were subjected to heat treatment to 
examine the effect of heat inactivated bacteria. Live bacteria cells were incubated at 80 0C for 30 minutes 
to produce heat killed inactivated bacteria (HIB). 
 
Passaging of Caco2 Cells 
Cultured cells were grown until they attained 70 % confluence. To detach the cells, 3 ml of trypsin-
EDTA was added to flask containing attached cells. Cells were incubated at 37 oC for 7 minutes for cells to 
entirely detach from the bottom of the flask. DMEM was immediately added to the flask after incubation 
to stop trypsin activity. Cells were spun at 200 g for 5 minutes and trypsin containing media was aspirated. 
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Caco2 cells were re-suspended in fresh complete growth media and dispensed into cell culture flasks, this 
procedure was repeated 6 times in order to prolong lives of cells in the culture by avoiding the senescence 
that is associated with prolonged high cell density.  
 
Cell Culture of Human Adenocarcinoma Cells (Caco2 cells) 
Caco-2 cell line was obtained and cultured in DMEM containing 100 µg/ml Penicillin-Streptomycin 
(Pen-Strep) supplemented with 10 % FBS and 5 % sodium pyruvate at 37 0C in a humidified atmosphere 
with 5 % CO2 using 24-well plates until confluence. The cells were allowed to grow, attach and 
differentiate in culture flask until 16 days post confluence after which cells are believed to have undergone 
spontaneous differentiation to look like intestinal epithelia cells representing lining of the small intestine. 
 
Preparing Lipid Mixture 
A 100x lipid mixture was prepared in 1 ml micro-centrifuge tube. The Lipid mixture contained 48 
mg of sodium taurocholate (NaTc), 50 mg oleic acid, 40 mg egg lecithin (lecithin is very sticky), 50 ml of PBS 
and the volume was made up to 900 ul to obtain 1x lipid mixture. The Lipid mixture was incubated at 37 oC 
and vortexed so that the concentrations (oleic acid, lecithin and sodium taurocholate (NaTc)) were 2.0 
mM, 1.36 mM and 1.0 mM respectively. The final solution was added to 89.1ml of ready to use complete 
growth media and filtered using 0.22 millipore filter. 
 
Cell Viability Assay 
Differentiated Caco2 cells were treated with 100 ul or 200 ul or 300 ul of the lipid mixture and 
incubated for 2 hrs. at 37 oC. Treated cells were trypsinized with 200 ul of trypsin-EDTA per well and 
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incubated for 7 minutes at 37 oC until they were completely detached from the bottom of the plate. They 
were spun at 200 g for 5 minutes and resuspended in PBS pH 7.4. The cell suspension of approximately 
1×106 cells/mL was prepared in PBS pH 7.4 and the sample was thoroughly mixed. A 1:1 mixture of the cell 
suspension and 0.4 % trypan blue solution was prepared by adding 200 ul of cell suspension to an equal 
amount of trypan blue solution. The sample was gently mixed and allowed to sit for 5 min at room 
temperature. Prior to use, the hemocytometer and coverslip were washed with 70 % (v/v) ethanol and 
allowed to dry. Fifteen microliters (15 ml) of cell suspension was added to the chamber through the edge 
of the chamber between the cover slip and the V-shaped groove in the chamber. The cell suspension was 
drawn into the chamber by capillary action. It was allowed to sit for 1–2 min and then cells were viewed 
using phase contrast microscope and viable and non-viable cells were counted using ASIO SOFTWARE. 
To evaluate the effect of oleic acid on cell viability, cell suspension of approximately 1×106 cells/mL 
of Caco2 cells treated with 100 ul, 200 ul and 300 ul of lipid mixture containing oleic acid was prepared in 
PBS pH 7.4 and samples were thoroughly mixed. A 1:1 mixture of the cell suspension and 0.4 % trypan blue 
solution was prepared by adding 200 ul of cell suspension to an equal amount of trypan blue solution. 
Viable and non-viable cells were enumerated using hemocytometer. 
 
 
Number of cells (viable or non-viable)  
= (A+B+C+D) x 104 x 2 x sample dilution 
          4 
% Viable cells = Number of viable cells 
                             Total number of cells 
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Probiotic Co-culture with Caco2 Cells 
Differentiated Caco2 cells were treated with 200 ul of the test strain's suspension containing 
approximately 107 CFU/ml of live L. rhamnosus or heat inactivated bacteria (HIB) or the cell free culture 
supernatant which is the filtered spent broth (FSB) or cytoplasmic fraction (CF) or growth media as control. 
Treated cells were incubated overnight (approximately 16hrs) at 37 0C and 5 % CO2. 
 
Treatment of Caco2 cells with Dietary Lipids 
Caco2 cells co-cultured overnight with live bacteria or bacteria extracts were divided into three 
treatment Protocols. Protocol 1’s overnight spent media was discarded and cells were directly overlaid 
without washing with 400 ul of fresh growth media containing 100 ul lipid mixture; Protocol 2 cells were 
washed three times in phosphate buffer saline (PBS), pH 7.4 and treated with lipid and fresh treatments; 
and Protocol 3 cells were washed three times in PBS and treated with 400 ul of complete growth media 
containing 100 ul lipid mixture in media without the treatments. Caco2 cells were incubated for 2 hrs as 
determined by the preliminary study at 37 0C, 5 % CO2. Cells were washed in PBS three times and lipid 
content was determined using Oil-Red O staining method (ORO). Accumulated intracellular triglyceride 
was also quantified using triglyceride reagent. 
 
Determination of Optimum Lipid Accumulation Time in Enterocytes 
Caco2 cells were seeded into 24-well plates after 5-6 passages. Cells were grown for about 5-6 days 
until they attained almost 100 % confluence. Cells were allowed to continue growing until 21-day post 
confluence. Cells were treated with 400 ul of complete growth media containing 100 ul lipid mixture (oleic 
acid, lecithin and sodium taurocholate (NaTc) and incubated for 30 mins, 1 hr, 2 hrs, 3 hrs or 4 hrs. Caco2 
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cells were harvested after each incubation period and subjected to intracellular triglyceride accumulation 
analysis and Oil-Red O staining assay to quantify and compare the level of lipid uptake by cells at each time 
point. 
 
Incorporated Lipid Content Quantification Assay (Oil-Read-O Staining) 
Intracellular lipid accumulation was measured using Oil-Red-O staining (ORO). Caco2 cells were 
cultured as described above.  When the cells had differentiated, they were treated with different 
concentrations of live bacteria (LB) or heat inactivated bacteria (HIB) or cytoplasmic fraction (CF) or filtered 
spent broth (FSB) or growth media (as a control) and were incubated overnight at 37 oC. After incubation, 
co-cultured cells were collected, and subjected to treatment with lipids as described above. At the end of 
the incubation, growth media was aspirated and 10 % formaldehyde was added to the wells and allowed 
to act for 5 minutes. Formaldehyde was removed and fresh formaldehyde was added and allowed to sit for 
at least 1 hour. The formaldehyde was removed and wells were washed with 60 % isopropanol and 
allowed to dry completely.  At this point, Oil-Red-O working solution (To prepare Oil Red O stock solution, 
60 mg of Oil Red O was dissolved in 20 ml of 100 % isopropyl-alcohol. Oil Red O working solution (prepared 
by adding 3 parts of Oil Red O stock solution to 2 parts of distilled water, the solution was allowed to sit for 
10 minutes and then filtered using Whatman filter paper) was added to wells and incubated for 10 
minutes.  The solution was removed and the wells were immediately washed with distilled water (dH2O) 
until no more red flakes were observed in the waste water.  Wells were then allowed to dry. Caco2 cells 
were observed using phase contrast microscope for appearance of stained lipid droplets in the cells. 
To quantify the lipid content in the wells, elution of Oil-Red-O stain was performed by adding 100 % 
isopropanol to the wells and allowed to sit for 10 minutes. The isopropyl-alcohol was pipetted several 
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times to remove all stain from the wells. The resulting solution was transferred into spectrophotometric 
cuvettes, lipid content in the isopropanol was determined using spectrophotometry method at an optical 
density of 492 nm. 
 
Quantification of Intracellular Triglyceride Accumulation 
Triglyceride reagent was obtained from Pointe Scientific Inc. and reconstituted with 15ml of 
distilled water. Treated cells were harvested and lysed using 1000 ul RIPA (Radioimmunoprecipitation 
assay) buffer (Cat No: BP-115) and 40 ul Protease inhibitor, by adding 200 ul of RIPA buffer per well. 
Samples were transferred into 1.5 ml micro-centrifuge tube and sonicated at 44 % amplitude on ice to 
ensure cells are totally lysed. Tubes containing cells were incubated at 4 oC for 30 minutes, cells were spun 
at 3000 g, 4 oC for 5 minutes and the supernatant collected. A hundred microliter (100 ul) of already 
reconstituted triglyceride reagent was added to a 96 well micro-titer plate and incubated at 37 oC for 3 
minutes. Ten microliters (10 ul) of samples were added to each well containing the reagent and incubated 
at 37 oC for 5 minutes. Caco-2 cell’s triglyceride content was determined by spectrophotometry. 
Absorbance was measured at an optical density of 540 nm. 
 
Determination of Protein Concentration (BCA) 
Solution of protein standard with a concentration of 1 mg/ml was prepared. A hundred microliter 
of distilled water was used as blank. Protein samples were prepared by diluting 10 µl of protein in 
surfactant in 90 µl of distilled water making a total volume 100 µl. BCA reagent was prepared by mixing 
reagent A (a solution containing bicinchoninic acid, sodium carbonate, sodium tartrate and sodium 
bicarbonate in 0.1 N NaOH, pH 11.25) and B (containing 4 % (w/v) CuSO4.5H2O) (Smith et al., 1985) in the 
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ratio 50:1. Two microliter (2 ul) of the BCA working reagent was added to each sample and standard, 
samples were gently vortexed and incubated at 370C for 30 minutes. The blank, protein standard and the 
unknown samples were transferred to a 96 well spectrophotometric plate and absorbance of all samples 
was measured at an optical density of 540 nm wavelength using a spectrophotometer. Calibration curve of 
standard protein sample concentration was plotted against the optical density. The concentration of 
unknown samples was determined using the standard calibration curve. 
 
Western Blot Analysis 
Overnight Caco2 cells treated according to Protocol 1 (overnight cells were overlaid with 100 ul of 
lipid mixture in 400 ul of growth media), Protocol 2 (overnight cells were washed and treated with 100 ul 
of lipid mixture in growth media and fresh treatments) and Protocol 3 (overnight cells were washed and 
treated with 100 ul of lipid mixture growth media only). Caco2 cells treated with 100 ul of lipid in 400 ul 
complete growth media was used to as control. Plates were incubated for 2 hrs. Cell culture dish was 
placed on ice. Cells were washed with ice-cold PBS. PBS was aspirated and attached cells were lysed using 
ice-cold lysis buffer (RIPA buffer (1 ml/107 cells/100 mm dish/150 cm2 flask). Adherent cells were scrapped 
off the dish using cold plastic cell scrapper. Different cell treatments were gently transferred into pre-
cooled micro-centrifuge tubes and centrifuged at 14,000 g for 30 minutes at 4 0C. The supernatant was 
separated from pellets and was transferred into new micro-centrifuge tubes and kept on ice. Equal volume 
of 2x Laemmli Sample Buffer and protein samples were prepared. Proteins were denatured by boiling 
samples in buffer at 90 0C for 10 minutes. 
Twenty microliters of each protein sample were loaded into each well alongside with molecular 
weight marker protein standard. Samples were run through 10 % SDS-PAGE gel for 60 minutes at 200 V. 
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Nitrocellulose membrane was activated in methanol for 1 minute and rinsed in transfer buffer. Resolved 
protein was transferred to nitrocellulose membrane. The membrane was blocked for 1 hr at room 
temperature using 3 % bovine serum albumin (BSA) with agitation in Tris-Buffered saline with Tween-20 
(TBST). The membrane was incubated with primary antibodies reconstituted with the blocking buffer 
against MTP, FABP, LPAAT (GPAT3) and NPC1L1 overnight in a cold room with agitation. The membrane 
was washed in TBST and incubated at room temperature for 60 minutes with the recommended dilution of 
the labeled secondary antibody reconstituted in blocking solution with agitation. The membrane was 
prepared for chemiluminescence exposure by placing it in 1:1 ratio volume of Super-Signal West Femto 
Maximum Sensitivity Substrate and allowed to sit for 5 minutes without agitation. The membrane was 
placed in a plastic wrap (sheet protector) to prevent drying. Chemiluminescence image or normal image 
exposure for protein detection was carried out. 
 
Statistical Analysis 
Experimental data were analyzed using one way analysis of variance (ANOVA). Comparison of 
individual and group data were performed and multiple range test was carried out to separate means 
(Bonferonni, Sidak and Scheffe methods). Differences in mean were analyzed at 5 % significant level. 
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CHAPTER 3 
RESULTS 
Effect of Oleic Acid on Cell Viability 
  Approximately 91 % of cells treated with 100 ul of lipid mixture remained viable after the 
treatment (Table 1). There was a slight reduction in viability to about 80 % of cells treated with 200 ul lipid 
mixture. Treatment with 300 ul of lipid led to drastic reduction in viability of cells to 44.27 %.  
 
Table 1: Effect of lipid mixture on Caco-2 cell viability (Trypan blue staining) * 
Cell/Trypan 
blue (v/v) 
Total 
number of 
cells 
Number of 
viable cells 
Number of non-
viable cells 
% viable 
cells 
% non-viable 
cell 
100 ul 1.5 x 106 1.2 x 106 3.15 x 105 90.5 % 9.5 % 
200 ul 1.61 x 106 1.13 x 106 4.8 x 105 80.18 % 19.82 % 
300 ul 2.06 x 106 5.0 x 105 1.56 x 106 44.27 % 55.73 % 
*Values represent mean percentage of viable and non-viable cells (n=3). 
 
Optimum Lipid Accumulation Time 
Total Lipid Content Accumulation 
Ideal time for lipid accumulation in Caco2 cells was determined by treating differentiated cells for 
different time frames (60, 120, 180 and 240 minutes) Lipid accumulation increased with time (Figure 3). 
The total lipid content level of cell was 0.097 at 1hr of incubation and was found to be at its maximum at 2 
hrs of incubation with lipid level of 0.184. After 2 hrs the intracellular lipid content level began to decrease. 
The lipid content level was 0.159 and 0.105 at 3hrs and 4hrs respectively.   
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Figure 3. Optimum incubation time for total lipid accumulation in Caco2 cells determined by Oil Red O 
staining assay. Total lipid content was determined by spectrophotometry and absorbance was measured 
at optical density (OD) at 492 nm. Each bar represents mean ± SD (n=3). 
 
 
Intracellular Triglyceride Accumulation 
             To establish the optimum time for lipids to accumulate in the cell, the triglyceride (TG) content of 
Caco2 cells was determined using TG reagent (Figure 4). Intracellular accumulated TG for 60, 120, 180 and 
240mins were 0.248, 0.283, 0.214 and 0.223 respectively. The intracellular TG level increased until 2 hrs of 
incubation and was maximum at 2 hrs compared with the control. The TG level began to decrease after 2 
hrs of incubation.  
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Figure 4. Triglyceride accumulation (TG) in Caco2 cells determined by spectrophotometry at Optical 
density of 540nm. Each bar represents mean ± SD value of calculated TG level (n=3). 
 
Total Lipid Content Assay 
Total Lipid Content of Caco2 Cells Treated According to Protocol 1 
In Protocol 1, overnight co-cultured Caco2 cells were overlaid with the lipid mixture without 
washing off the treatments (Table 2). The TL level of cells overlaid with CF, HIB and LB compared to the 
control were 0.13, 0.25 and 0.91 respectively (Figure 5). The total lipid level (TL) increased by 0.13 
compared to the control in cells treated with FSB, although there was slight decrease of 0.13 and 0.25 in 
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cells treated with CF and HIB respectively. LB decreased the TL level in Caco2 cells by 0.91 when compared 
with the control and other treatments.  
 
Figure 5. Effect of Lactobacillus rhamnosus MRS6AN or its extracts on total cellular lipid level (determined 
by spectrophotometry) in Caco2 cells treated according to Protocol 1 (after overnight bacterial treatments, 
cells were overlaid with lipid mixture without washing and incubated for 2 hrs). Optical density was 
measured at 492 nm. Each bar represents mean ± SD of total cellular lipid content (n=3). Treatments 
include CF (cytoplasmic fraction), FSB (filtered spent broth), HIB (heat inactivated bacteria), LB (live 
bacteria) and the control. Bars labelled with different letters are statistically different from each other 
(P≤0.05). 
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Table 2: Effect of L. rhamnosus MRS6AN or its extracts on total cellular lipid content of Caco2 cells treated 
according to Protocol 1 (after overnight bacterial treatments, cells were overlaid with lipid mixture without 
washing and incubated for 2 hrs). Treatments include CF (cytoplasmic fraction), FSB (filtered spent broth), 
HIB (heat inactivated bacteria), LB (live bacteria) and the control. 
 
 
Treatment (200 ul) 
 
Total Lipid Content (OD492nm) 
 
Control 1.48 
Cytoplasmic fraction 1.35 
Filtered Spent broth 1.61 
Heat inactivated bacteria 1.23 
Live bacteria 0.57 
 
Total Lipid Content of Caco2 Cells Treated According to Protocol 2 
In Protocol 2, co-cultured cells were washed and treated with lipid and live bacteria or its extracts. 
A greater reduction of total lipid content of Caco2 cells was observed in LB and CF treated cells treated 
according to Protocol 2 compared with the control (Table 3). HIB and FSB treatments did not reduce TL 
content in cells. The decrease in TL level in LB and CF treated cells was by 0.51 and 0.27 when compared to 
the control (Figure 6). On the contrary, HIB treated cells showed slight increase in cellular TL content with 
0.17.  
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Figure 6. Effect of Lactobacillus rhamnosus MRS6AN or its extracts on total cellular lipid content 
(determined by spectrophotometry) in Caco2 cells treated according to Protocol 2 (after overnight 
bacterial treatment, cells were washed and treated with lipid mixture and fresh bacteria treatment and 
incubated for 2 hrs). Optical density was measured at 492 nm. Each bar represents mean ± SD value of 
total cellular lipid content (n=3). Treatments include CF (cytoplasmic fraction), FSB (filtered spent broth), 
HIB (heat inactivated bacteria), LB (live bacteria) and the control. 
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Table 3. Effect of L. rhamnosus MRS6AN or its extracts on total cellular lipid content of Caco2 cells treated 
according to Protocol 2 (after overnight bacterial treatment, cells were washed and treated with lipid 
mixture and fresh bacteria treatment and incubated for 2 hrs). Treatments include CF (cytoplasmic 
fraction), FSB (filtered spent broth), HIB (heat inactivated bacteria), LB (live bacteria) and the control. 
 
 
 
 
 
 
 
 
Total Lipid Content of Caco2 Cells Treated According to Protocol 3 
In Protocol 3, overnight co-cultured cells were washed and treated with 100 ul lipid mixture only. 
The LB and CF induced reduction in TL content of 0.91 and 0.55 respectively, but was not significantly 
different when compared to the control (Figure 7). There was little or no change in TL level in the presence 
of FSB or HIB when compared to the control treatment. 
Treatment (200 ul) Total Lipid Content (OD492 nm) 
Control 1.48 
Cytoplasmic fraction 1.21 
Filtered Spent broth 1.39 
Heat inactivated bacteria 1.65 
Live bacteria 0.97 
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Figure 7. Effect of Lactobacillus rhamnosus MRS6AN or its extracts on total cellular lipid content 
(determined by spectrophotometry) in Caco2 cells treated according to Protocol 3 (After overnight 
bacterial treatment, cells were washed and treated with only the lipid mixture and incubated for 2 hrs). 
Optical density was measured at 492 nm. Each bar represents mean ± SD value of calculated total cellular 
lipid content (n=3). Treatments include CF (cytoplasmic fraction), FSB (filtered spent broth), HIB (heat 
inactivated bacteria), LB (live bacteria) and the control. Bars labelled with different letters are statistically 
different from each other (P≤0.05). 
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Table 4. Effect of Lactobacillus rhamnosus MRS6AN or its extracts on total cellular lipid content 
(determined by spectrophotometry) in Caco2 cells treated according to Protocol 3 (After overnight 
bacterial treatment, cells were washed and treated with lipid mixture only and incubated for 2 hrs.). 
Optical density was measured at 492 nm. Treatments include CF (cytoplasmic fraction), FSB (filtered spent 
broth), HIB (heat inactivated bacteria), LB (live bacteria) and the control. 
 
Treatment (200 ul) Total Lipid Content (OD492 nm) 
Control 1.48 
Cytoplasmic fraction 0.94 
Filtered Spent broth 1.50 
Heat inactivated bacteria 1.50 
Live bacteria 1.48 
 
Comparison Between Effect of Probiotic Treatments on Total Lipid Content between Treatment Protocols. 
Cytoplasmic Fraction (CF) Treatment 
The total lipid content of Caco2 cells treated with CF (cytoplasmic fraction) were compared across 
treatment Protocols to determine whether there were differences in their TL content. Although there was 
no significant difference between CF treated cells, but there was a greater reduction in TL content of cells 
treated according to Protocol 3 compared to other Protocols and the control treatment. The level of TL in 
cells treated according to Protocols 1 and 2 were slightly lower when compared to the control treatment. 
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Figure 8. Lipid content of Caco2 cells treated with bacterial cytoplasmic fraction (CF) according to 3 
treatment Protocols: Protocol 1 (after overnight bacterial treatment, cells were overlaid with lipids without 
washing), Protocol 2 (after overnight bacterial treatment, cells were washed and treated with lipids and 
fresh treatments) and Protocol 3 (after overnight bacterial treatment, cells were washed and treated with 
lipids only). Optical density measurements were determined via spectrophotometry at 492 nm. Each bar 
represents mean ± SD value of calculated total cellular lipid content (n=3). Bars labelled with different 
letters are statistically different from each other (P≤0.05). 
 
Filtered Spent Broth (FSB) Treatment 
The total lipid content of Caco2 cells treated with FSB (filtered spent broth) were compared in all 
treatment Protocols to determine whether there were differences in their TL content. There was no 
significant difference in TL content of Caco2 cells cells between all the Protocols and relative to the control 
treatment.  
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Figure 9. Lipid content for Caco2 cells treated with filtered spent broth (FSB) according to 3 treatment 
Protocols: Protocol 1 (after overnight bacterial treatment, cells were overlaid with lipids without washing), 
Protocol 2 (after overnight bacterial treatment, cells were washed and treated with lipids and fresh 
treatments) and Protocol 3 (after overnight bacterial treatment, cells were washed and treated with lipids 
only). Optical density measurements were determined via spectrophotometry at 492 nm. Each bar 
represents mean ± SD value of calculated total cellular lipid content (n=3). Bars labelled with different 
letters are statistically different from each other (P≤0.05). 
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Heat Inactivated Bacteria (HIB) Treatment 
The total lipid content of Caco2 cells treated with HIB (heat inactivated bacteria) were compared 
across treatment Protocols to determine whether there were differences in their TL content (Figure 10). 
There was reduction in TL content of cells treated according to Protocol 1 and 3 but was not significantly 
different compared to other Protocols and relative to the control treatment. There was no reduction in TL 
content of cells treated according to Protocol 2. 
 
Figure 10. Lipid content of Caco2 cells treated with bacterial heat inactivated bacteria (HIB) according to 3 
treatment Protocols: Protocol 1 (after overnight bacterial treatment, cells were overlaid with lipids without 
washing), Protocol 2 (after overnight bacterial treatment, cells were washed and treated with lipids and 
fresh treatments) and Protocol 3 (after overnight bacterial treatment, cells were washed and treated with 
lipids only). Optical density measurements were determined via spectrophotometry at 492 nm. Each bar 
represents mean ± SD value of calculated total cellular lipid content (n=3). Bars labelled with different 
letters are statistically different from each other (P≤0.05). 
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Live Bacteria (LB) Treatment 
The total lipid content of Caco2 cells treated with LB (live bacteria) were compared across 
treatment Protocols to determine whether there were differences in their TL content. There was reduction 
in TL content of cells treated according to Protocol 1 and 2, but TL level was not significantly difference 
compared to other Protocols and relative to the control treatment. There was however no change in TL 
content of cells treated according to Protocol 3. 
 
Figure 11. Lipid content of Caco2 cells treated with live Lactobacillus rhamnosus MRS6AN(LB) according to 
3 treatment Protocols: Protocol 1 (after overnight bacterial treatment, cells were overlaid with lipids 
without washing), Protocol 2 (after overnight bacterial treatment, cells were washed and treated with 
lipids and fresh treatments) and Protocol 3 (after overnight bacterial treatment, cells were washed and 
treated with lipids only). Optical density measurements were determined via spectrophotometry at 492 
nm. Each bar represents mean ± SD value of calculated total cellular lipid content (n=3). Bars labelled with 
different letters are statistically different from each other (P≤0.05). 
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Intracellular Triglyceride Assay 
Intracellular Triglyceride Content of Co-Cultured Caco2 Cells Treated According to Protocol 1 
In Protocol 1, co-cultured Caco2 cells were overlaid with lipid without washing. A greater and 
significant reduction of TG accumulation was observed in cells treated with LB compared to the control. 
Other treatments did not induce significant reduction in intracellular TG content. LB significantly lowered 
level of TG in cell by 0.1 (P<0.05) relative to the control. Cells treated with CF or HIB decreased TG level in 
cells by 0.03 and 0.06 relative to the control treatment. There was no significant change in TG level of cells 
treated with FSB relative to the control. 
 
Figure 12. Total intracellular triglyceride level of Caco2 cells treated according to Protocol 1 (after 
overnight bacterial treatment, cells were overlaid with lipid mixture without washing and incubated for 2 
hrs). Quantification of triglyceride content was determined by spectrophotometry at 540nm. Each bar 
represents mean ± SD value of calculated intracellular triglyceride content (n=3). Bars labelled with 
different letters are statistically different from each other (P≤0.05). 
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Table 5. Effect of L. rhamnosus MRS6AN or its extracts on total intracellular triglyceride content of Caco2 
cells treated according to Protocol 1 (After overnight bacterial treatment, cells were overlaid with lipid 
mixture without washing and incubated for 2 hrs.). Optical density was measured at 540 nm. Treatments 
include CF (cytoplasmic fraction), FSB (filtered spent broth), HIB (heat inactivated bacteria), LB (live 
bacteria) and the control. 
 
Treatment (200ul) Triglyceride level (OD540 nm) 
Control 0.20 
Cytoplasmic fraction 0.17 
Filtered Spent broth 0.21 
Heat inactivated bacteria 0.14 
Live bacteria 0.10 
 
Intracellular Triglyceride Content of Co-Cultured Caco2 Cells Treated According to Protocol 2 
In Protocol 2, co-cultured cells were washed and treated with lipid mixture and live bacteria or its 
extracts. A significant reduction in TG accumulation was observed in LB treated cells compared with the 
control (Figure 13). LB induced significant reduction in TG level of cell by 0.076 compared to the control 
treatment (P< 0.05). Other treatments did not induce significant change in TG level of Caco2 cells. 
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Figure 13. Total intracellular triglyceride level of Caco2 cells treated according to Protocol 2 (after 
overnight bacterial treatment, cells were washed and treated with lipid mixture and fresh bacteria 
treatments and incubated for 2 hrs.). Quantification of triglyceride content was determined by 
spectrophotometry at 540nm. Each bar represents mean ± SD value of calculated intracellular triglyceride 
content (n=3). Bars labelled with different letters are statistically different from each other (P≤0.05). 
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Table 6. Effect of L. rhamnosus MRS6AN or its extracts on total cellular lipid content of Caco2 cells treated 
according to Protocol 2 (After overnight bacterial treatment, cells were washed and treated with lipid 
mixture and fresh bacteria treatments and incubated for 2 hrs.). Optical density was measured at 540 nm. 
Treatments include CF (cytoplasmic fraction), FSB (filtered spent broth), HIB (heat inactivated bacteria), LB 
(live bacteria) and the control. 
 
Treatment (200ul) Triglyceride level (OD540 nm) 
Control 0.20 
Cytoplasmic fraction 0.17 
Filtered Spent broth 0.20 
Heat inactivated bacteria 0.17 
Live bacteria 0.12 
 
Intracellular triglyceride content of co-cultured Caco2 cells treated according to Protocol 3 
In Protocol 3, overnight co-cultured Caco2 cells were washed and treated with fresh lipid mixture. 
There was no inhibitory effect on TG level of cells treated with CF, FSB and HIB respectively when 
compared to the control (Figure 14). However, treatment with LB induced slight reduction of 0.05 in the 
intracellular TG level when compared to the control. 
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Figure 14. Total intracellular triglyceride level of Caco2 cells treated according to Protocol 3 (after 
overnight bacterial treatment, cells were washed and treated with lipid mixture only and incubated for 2 
hrs). Quantification of triglyceride content was determined by spectrophotometry at 540nm. Each bar 
represents mean ± SD value of calculated intracellular triglyceride content (n=3). Bars labelled with 
different letters are statistically different from each other (P≤0.05). 
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Table 7. Effect of L. rhamnosus MRS6AN or its extracts on total cellular lipid content of Caco2 cells treated 
according to Protocol 3 (after overnight treatment, cells were washed and treated with lipid mixture only 
and incubated for 2 hrs). Optical density was measured at 540 nm. Treatments include CF (cytoplasmic 
fraction), FSB (filtered spent broth), HIB (heat inactivated bacteria), LB (live bacteria) and the control. 
 
 
Treatment (200 ul) 
 
Triglyceride level (OD540 nm) 
 
Control 0.20 
Cytoplasmic fraction 0.16 
Filtered Spent broth 0.14 
Heat inactivated bacteria 0.21 
Live bacteria 0.15 
 
 
Comparison Between Effects of Probiotic Treatments on Intracellular TG Content between Treatment 
Protocols. 
Effect of Bacterial Cell Extract on Intracellular TG Level in Caco-2 Cell-Lysate 
The cytoplasmic fraction (CF) treated cells (treated according to Protocol 3) demonstrated the 
lowest TG level of 0.05 but with no significance difference compared to other Protocols and the control 
treatment (Figure 15). However, CF treated cells in Caco2 cells in Protocol 1 (overlaid with lipids without 
washing) or Protocol 2 (washed and treated with lipids and bacterial treatments) no significant effect on 
intracellular TG content relative to the control. 
65 
 
 
Figure 15. Intracellular triglyceride content of Caco2 cells treated with bacterial cytoplasmic fraction (CF) 
according to 3 treatment Protocols: Protocol 1 (after overnight bacterial treatment, cells were overlaid 
with lipids without washing), Protocol 2 (after overnight bacterial treatment, cells were washed and 
treated with lipids and fresh treatments) and Protocol 3 (after overnight bacterial treatment, cells were 
washed and treated with lipids only). Absorbance was determined via spectrophotometry at optical 
density of 540 nm. Each bar represents mean ± SD value of calculated intracellular triglyceride content 
(n=3). Bars labelled with different letters are statistically different from each other (P≤0.05). 
 
Effect of Bacterial Filtered Spent Broth on Intracellular TG Level in Caco2 Cells 
Bacterial filtered spent broth (FSB) treated cells in Protocol 1 (overlaid with lipids without washing) 
demonstrated negligible reduction in TG level of 0.06 compared to the control (Figure 16). Although FSB 
treated Protocols 1 and 2 showed no considerable change in TG level of Caco2 cells, there was however a 
significant increase in intracellular TG level of cells treated according to protocol 3 compared with cells 
treated according to protocol 1. 
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Figure 16. Intracellular triglyceride content of Caco2 cells treated with bacterial filtered spent broth 
according to 3 treatment Protocols: Protocol 1 (after overnight bacterial treatment, cells were overlaid 
with lipids without washing), Protocol 2 (after overnight bacterial treatment, cells were washed and 
treated with lipids and fresh treatments) and Protocol 3 (after overnight bacterial treatment, cells were 
washed and treated with lipids only). Each bar represents mean ± SD value of calculated intracellular 
triglyceride content (n=3). Absorbance was determined via spectrophotometry at optical density of 540 
nm. Each bar represents mean ± SD value of calculated intracellular triglyceride content (n=3). Bars 
labelled with different letters are statistically different from each other (P≤0.05). 
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Effect of Heat Inactivated Bacteria (HIB) on Intracellular Triglyceride Level 
Heat Inactivated bacteria (HIB) treated cells as per Protocol 3 (washed and treated with lipids only) 
exhibited a significant increase in Caco-2 cell TG level by 0.07 compared to the treatment according to 
protocol 1 (Figure 17). Cells treated according to all treatment protocols demonstrated no significant 
change in intracellular TG content relative to the control.  
 
Figure 17. Intracellular triglyceride content of Caco2 cells treated with heat inactivated bacteria (HIB) 
according to 3 treatment Protocols: Protocol 1 (after overnight bacterial treatment, cells were overlaid 
with lipids without washing), Protocol 2 (after overnight bacterial treatment, cells were washed and 
treated with lipids and fresh treatments) and Protocol 3 (after overnight bacterial treatment, cells were 
washed and treated with lipids only). Absorbance was determined via spectrophotometry at optical 
density of 540 nm. Each bar represents mean ± SD value of calculated intracellular triglyceride content 
(n=3). Bars labelled with different letters are statistically different from each other (P≤0.05). 
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Effect of Live Bacteria (LB) on Intracellular TG Level in Caco-2 Cell 
Live bacteria (LB) applied as per Protocol 2 (after overnight bacterial treatment, cells were washed 
and treated with lipids and fresh treatments) and Protocol 3 (after overnight bacterial treatment, cells 
were washed and treated with lipids only) significantly reduced TG level by 0.1 and 0.08 relative to the 
control (Figure 18). However, LB applied as per Protocol 1 (overlaid with lipids without washing) induced 
the lowest TG level of 0.1 when compared to the control.  
 
Figure 18. Intracellular triglyceride content of Caco2 cells treated with live Lactobacillus rhamnosus 
MRS6AN (LB) according to 3 treatment Protocols: Protocol 1 (after overnight bacterial treatment, cells 
were overlaid with lipids without washing), Protocol 2 (after overnight bacterial treatment, cells were 
washed and treated with lipids and fresh treatments) and Protocol 3 (after overnight bacterial treatment, 
cells were washed and treated with lipids only). Absorbance was determined via spectrophotometry at 
optical density of 540 nm. Each bar represents mean ± SD value of calculated intracellular triglyceride 
content (n=3). Bars labelled with different letters are statistically different from each other (P≤0.05). 
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Effect of Probiotic Treatments on MTP Expression 
               The MTP protein expression analysis revealed that LB treatments in all Protocol 1 (after overnight 
bacterial treatment, cells were overlaid with lipids without washing), Protocol 2 (after overnight bacterial 
treatment, cells were washed and treated with lipids and fresh treatments) and Protocol 3 (after overnight 
bacterial treatment, cells were washed and treated with lipids only) induced observable reduction in MTP 
expression at 5.50, 4.16 and 5.59-fold respectively compared to the control treatment, with the highest 
protein reduction being in Protocol 3 (Figure 19 and Table 8). There was little or no change in expression in 
all cells treated with FSB in Protocols 2 and 3. Heat inactivated bacteria treatment caused slight protein 
reduction in Protocols 1 and 2 with 1.59 and 1.43-fold reduction respectively.  
 
Figure 19. Western blot assay image of MTP expression in Caco2 cells 
(CF- Cytoplasmic fraction, FSB- Filtered spent broth, HIB- Heat inactivated bacteria, LB- Live bacteria). 
 
MTP Expression of Co-Cultured Caco2 Cells Treated According to Protocol 1 
Co-cultured Caco2 cells were overlaid with lipid without washing, after an overnight incubation 
period (Figure 20). A significant reduction in MTP expression was observed in cells treated with LB 
compared to other treatments and the control. Other treatments did not induce significant change in MTP 
expression of cells. LB significantly lowered MTP expression in cell by 6.35 (P<0.05) relative to the control. 
Cells treated with CF, FSB or HIB did not show significant change in MTP expression relative to the control. 
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Figure 20. Effect of Lactobacillus rhamnosus MRS6AN or its extracts on MTP expression in Caco2 cells 
treated according to Protocol 1 (after overnight bacterial treatment, cells were overlaid with lipid mixture 
without washing and incubated for 2 hrs). Each bar represents mean ± SD value of percent fold change 
(n=3). Treatments include CF (cytoplasmic fraction), FSB (filtered spent broth), HIB (heat inactivated 
bacteria), LB (live bacteria) and the control. Bars labelled with different letters are statistically different 
from each other (P≤0.05). 
 
 
MTP Expression of Co-Cultured Caco2 Cells Treated According to Protocol 2 
Overnight treated cells were washed 3 times in PBS, and treated with fresh bacteria treatments. 
Changes in MTP expression was not significantly different among all treatments and the control (Figure 
21). Nevertheless, LB treatment slightly lowered MTP expression in cell by 4.4 relative to the control. 
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Figure 21. Effect of Lactobacillus rhamnosus MRS6AN or its extracts on MTP expression in Caco2 cells 
treated according to Protocol 2 (after overnight bacterial treatment, cells were washed and treated with 
lipid mixture and fresh bacterial treatments and incubated for 2 hrs). Each bar represents mean ± SD value 
of percent fold change (n=3). Treatments include CF (cytoplasmic fraction), FSB (filtered spent broth), HIB 
(heat inactivated bacteria), LB (live bacteria) and the control. Bars labelled with different letters are 
statistically different from each other (P≤0.05). 
 
 
MTP Expression of Co-Cultured Caco2 Cells Treated According to Protocol 3 
Caco2 cells treated according to protocol 3 (overnight co-cultured cells were washed and treated 
lipids only) showed significant reduction in MTP expression in cells treated with LB compared to FSB 
treated cells and the control by 5.3 and 5.94 respectively. Other treatments did not induce significant 
change in MTP expression of cells (Figure 22). 
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Figure 22. Effect of Lactobacillus rhamnosus MRS6AN or its extracts on MTP expression in Caco2 cells 
treated according to Protocol 3 (after overnight bacterial treatment, cells were washed and treated with 
lipid mixture only and incubated for 2 hrs). Each bar represents mean ± SD value of percent fold change 
(n=3). Treatments include CF (cytoplasmic fraction), FSB (filtered spent broth), HIB (heat inactivated 
bacteria), LB (live bacteria) and the control. Bars labelled with different letters are statistically different 
from each other (P≤0.05). 
 
Effect of bacterial cytoplasmic fraction (CF) on MTP expression  
         There were no significant differences in MTP expression across all Protocols in Caco2 cells treated 
with bacteria cytoplasmic fraction (CF) and relative to the control treatment (Figure 23).  
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Figure 23. Effects of bacterial cell extracts (CF) on MTP expression in Caco2 cells. The CF was applied under 
three Protocol (Protocol 1: overnight co-culture Caco2 cells overlaid and incubated with lipids for 2 hrs, 
Protocol 2: overnight co-culture Caco2 cells washed, treated with lipids and fresh bacteria treatments and 
incubated for 2 hrs, Protocol 3: overnight co-culture Caco2 cells washed and incubated with lipids only for 
2 hrs). Each bar represents mean fold change relative to the control treatment (n=2 to 3). Bars labelled 
with different letters are statistically different from each other (P≤0.05). 
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Effect of Bacterial Filtered Spent Broth (FSB) on MTP Expression  
       The presence of filtered spent broth (FSB) did not induce any significant change in MTP expression 
level in Caco2 cells across all protocols (Figure 24).  
 
Figure 24. Effects of bacterial filtered spent broth (FSB) on MTP expression in Caco2 cells. The FSB was 
applied under three Protocol (Protocol 1: overnight co-culture Caco2 cells overlaid and incubated with 
lipids for 2 hrs, Protocol 2: overnight co-culture Caco2 cells washed, treated with lipids and fresh bacteria 
treatments and incubated for 2 hrs, Protocol 3: overnight co-culture Caco2 cells washed and incubated 
with lipids only for 2 hrs). Each bar represents mean fold change relative to the control treatment (n=2 to 
3). Bars labelled with different letters are statistically different from each other (P≤0.05). 
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Effect of Heat Inactivated Bacteria (HIB) on MTP Expression  
 
Lactobacillus rhamnosus was heat inactivated for 15 minutes at 90oC to determine the effect of 
heat killed bacteria on MTP expression in Caco2 cells. The result showed that heat inactivated bacteria 
induced no significant change in MTP expression of Protocol 1 (overnight co-culture Caco2 cells overlaid 
and incubated with lipids for 2 hrs), Protocol 2 (overnight co-culture Caco2 cells washed, treated with 
lipids and fresh bacteria treatments and incubated for 2 hrs) and Protocol 3 (overnight co-culture Caco2 
cells washed and incubated with lipids only for 2 hrs) and relative to the control treatment (Figure 25). 
 
Figure 25. Comparison of effects of heat inactivated bacteria (HIB) on MTP expression in Caco2 cells. The 
HIB was applied under three Protocol (Protocol 1: overnight co-culture Caco2 cells overlaid and incubated 
with lipids for 2 hrs, Protocol 2: overnight co-culture Caco2 cells washed, treated with lipids and fresh 
bacteria treatments and incubated for 2 hrs, Protocol 3: overnight co-culture Caco2 cells washed and 
incubated with lipids only for 2 hrs). Each bar represents mean fold change relative to the control 
treatment (n=2 to 3). Bars labelled with different letters are statistically different from each other 
(P≤0.05). 
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Effect of Bacterial Live Bacteria (LB) on MTP Expression  
           Lactobacillus rhamnosus MRS6AN significantly reduced MTP expression in Protocols 1 (overlaid with 
lipids without washing) and 3 (washed and treated with fresh bacterial treatments) when compared to the 
control treatment, nevertheless, Caco2 cells treated as per Protocol 1 induced the lowest MTP expression 
by 6.35 percentage fold-change relative to the control treatment (Figure 23). There was no considerable 
difference in MTP expression among the 3 protocols. 
 
Figure 26. Effects of live bacteria (LB) on MTP expression in Caco2 cells. LB was applied under three 
Protocol (Protocol 1: overnight co-culture Caco2 cells overlaid and incubated with lipids for 2 hrs, Protocol 
2: overnight co-culture Caco2 cells washed, treated with lipids and fresh bacteria treatments and 
incubated for 2 hrs, Protocol 3: overnight co-culture Caco2 cells washed and incubated with lipids only for 
2 hrs). Each bar represents mean fold change relative to the control treatment (n=2 to 3). Bars labelled 
with different letters are statistically different from each other (P≤0.05). 
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Table 8. Effect of live L. rhamnosus MRS6AN, heat inactivated bacteria, filtered spent broth or its 
cytoplasmic fraction on MTP expression in Caco2 cells. 
 
 
TREATMENT 
 
CNTRL 
 
CF1 
 
CF2 
 
CF3 
 
FSB1 
 
FSB2 
 
FSB3 
 
HIB1 
 
HIB2 
 
HIB3 
 
LB1 
 
LB2 
 
 LB3 
MTP REL. 
EXPRESSION* 
 
9.78 
 
  9.56 
 
9.25 
 
7.53 
 
8.87 
 
8.88 
 
9.15 
 
9.53 
 
7.79 
 
7.37 
 
3.43 
 
5.36 
 
3.84 
*Expression values are mean fold change, where n=1 to 4. Mean fold change represent protein expression 
relative to the control. 
 
Effect of Probiotic Treatments on GPAT3 Expression 
GPAT3 expression was significantly reduced in LB treated cells according to protocol 1 (overnight 
co-culture Caco2 cells overlaid with lipids without washing and incubated for 2 hrs), 2 (co-cultured cells 
washed and treated with fresh bacterial treatments)  and 3  (overnight co-culture Caco2 cells washed and 
incubated with lipids only for 2 hrs) compared to other treatments and the control (Figure 27 and Table 9) 
Furthermore, LB in Protocols 1, 2 and 3 lowered expression of GPAT3 by 7.32, 7.40 and 4.92-fold change 
respectively  relative to the control treatment. Other treatments induced no significant effect on GPAT3 
expression in all protocols relative to the control. 
Figure 27. Western blot assay image of GPAT3 expression in Caco2 cells 
(CF- Cytoplasmic fraction, FSB- Filtered spent broth, HIB- Heat inactivated bacteria, LB- Live bacteria) 
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GPAT3 expression of co-cultured Caco2 cells treated according to Protocol 1 
Co-cultured Caco2 cells were overlaid with lipid without washing, after an overnight incubation period. 
Significant reduction in GPAT3 expression was observed in Caco2 cells treated with LB compared to other 
treatments and the control (Figure 28). Other treatments did not induce significant change in GPAT3 
expression in cells. 
 
Figure 28. Effect of Lactobacillus rhamnosus MRS6AN or its extracts on MTP expression in Caco2 cells 
treated according to Protocol 1 (after overnight bacterial treatment, cells were overlaid with lipid mixture 
without washing and incubated for 2 hrs). Each bar represents mean ± SD value of percent fold change 
(n=3). Treatments include CF (cytoplasmic fraction), FSB (filtered spent broth), HIB (heat inactivated 
bacteria), LB (live bacteria) and the control. Bars labelled with different letters are statistically different 
from each other (P≤0.05). 
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GPAT3 Expression of Co-Cultured Caco2 Cells Treated According to Protocol 2 
Overnight co-cultured cells treated according to protocol 2 (cells washed and treated with fresh 
bacteria treatments) showed significant reduction in GPAT3 expression when treated with LB compared to 
other treatments and the control (Figure 29). There was however no significant change in GPAT3 
expression in other treatments relative to the control.  
 
Figure 29. Effect of Lactobacillus rhamnosus MRS6AN or its extracts on MTP expression in Caco2 cells 
treated according to Protocol 2 (after overnight bacterial treatment, cells were washed and treated with 
lipid mixture and fresh bacterial treatments and incubated for 2 hrs). Each bar represents mean ± SD value 
of percent fold change (n=3). Treatments include CF (cytoplasmic fraction), FSB (filtered spent broth), HIB 
(heat inactivated bacteria), LB (live bacteria) and the control. Bars labelled with different letters are 
statistically different from each other (P≤0.05). 
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GPAT3 Expression of Co-Cultured Caco2 Cells Treated According to Protocol 3 
LB treated Caco2 cells treated according to protocol 3 (overnight co-cultured cells were washed 
and treated lipids only) demonstrated significant reduction in GPAT3 expression compared to other 
treatments and the control (Figure 30). Other treatments did not induce significant change in GPAT3 
expression of cells. 
 
Figure 30. Effect of Lactobacillus rhamnosus MRS6AN or its extracts on MTP expression in Caco2 cells 
treated according to Protocol 3 (after overnight bacterial treatment, cells were washed and treated with 
lipid mixture only and incubated for 2 hrs). Each bar represents mean ± SD value of percent fold change 
(n=3). Treatments include CF (cytoplasmic fraction), FSB (filtered spent broth), HIB (heat inactivated 
bacteria), LB (live bacteria) and the control. Bars labelled with different letters are statistically different 
from each other (P≤0.05). 
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Effect of Bacterial Cytoplasmic Fraction (CF) on GPAT3 Expression  
Bacterial cytoplasmic fraction across all Protocols had no significant effect on GPAT3 expression 
(Figure 31).  
 
Figure 31. Comparison between the effects of bacteria cell extracts (CF) on GPAT3 expression in Caco2 
cells. The CF was applied under three Protocol (Protocol 1: overnight co-culture Caco2 cells overlaid and 
incubated with lipids for 2 hrs, Protocol 2: overnight co-culture Caco2 cells washed, treated with lipids and 
fresh bacteria treatments and incubated for 2 hrs, Protocol 3: overnight co-culture Caco2 cells washed and 
incubated with lipids only for 2 hrs). Each bar represents mean fold change relative to the control 
treatment (n=2 to 3). Bars labelled with different letters are statistically different from each other 
(P≤0.05). 
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Effect of Bacterial Filtered Spent Broth (FSB) on GPAT3 Enzyme 
There was no significant change in GPAT3 expression level in Protocols 1, 2 and 3 compared to the 
control (Figure 32).  
 
Figure 32. Comparison between the effects of bacterial filtered spent broth (FSB) on GPAT3 expression in 
Caco2 cells, The FSB was applied under three Protocol (Protocol 1: overnight co-culture Caco2 cells 
overlaid and incubated with lipids for 2 hrs, Protocol 2: overnight co-culture Caco2 cells washed, treated 
with lipids and fresh bacteria treatments and incubated for 2 hrs, Protocol 3: overnight co-culture Caco2 
cells washed and incubated with lipids only for 2 hrs). Each bar represents mean fold change relative to the 
control treatment (n=2 to 3). Bars labelled with different letters are statistically different from each other 
(P≤0.05). 
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Effect of Heat Inactivated Bacteria (HIB) on GPAT3 Enzyme  
In the presence of heat inactivated bacteria, there was no significant effect on the expression level 
of GPAT3 across Protocols relative to the control treatment. However, there was a slight reduction in 
expression in cells as per Protocol 1 (1.80-fold change relative to the control) (Figure 33). 
 
Figure 33. Effects of heat inactivated bacteria (HIB) on GPAT3 expression in Caco2 cells. The HIB was 
applied under three Protocol (Protocol 1: overnight co-culture Caco2 cells overlaid and incubated with 
lipids for 2 hrs, Protocol 2: overnight co-culture Caco2 cells washed, treated with lipids and fresh bacteria 
treatments and incubated for 2 hrs, Protocol 3: overnight co-culture Caco2 cells washed and incubated 
with lipids only for 2 hrs). Each bar represents mean fold change relative to the control treatment (n=2 to 
3). Bars labelled with different letters are statistically different from each other (P≤0.05). 
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Effect of Live Bacteria (LB) on GPAT3 Enzyme.  
There was significant down-regulation of GPAT3 expression in LB treated cells across all Protocols 
relative to the control with the lowest expression in cells treated according to protocol 1 (cells overlaid 
with lipids without washing) (Figure 34). Although, there were slight changes in GPAT3 expression between 
LB treated protocols, there was however no significant difference in GPAT3 expression between LB treated 
protocols. 
 
Figure 34. Comparison between the effects of live L. rhamnosus MRS6AN (LB) on GPAT3 expression in 
Caco2 cells. The LB was applied under three Protocol (Protocol 1: overnight co-culture Caco2 cells overlaid 
and incubated with lipids for 2 hrs, Protocol 2: overnight co-culture Caco2 cells washed, treated with lipids 
and fresh bacteria treatments and incubated for 2 hrs, Protocol 3: overnight co-culture Caco2 cells washed 
and incubated with lipids only for 2 hrs). Each bar represents mean fold change relative to the control 
treatment (n=2 to 3). Bars labelled with different letters are statistically different from each other 
(P≤0.05). 
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Table 9. Effect of L. rhamnosus MRS6AN, heat inactivated bacteria, filtered spent broth or its cytoplasmic 
fraction on GPAT3 expression in Caco-2 cells. 
 
*Expression values are mean fold change, where n=2, Mean fold change represent protein expression 
relative to the control. 
 
Effect of Probiotic Treatment on I-FABP Expression 
I-FABP expression in LB treated Caco2 cells in Protocol 2 (overnight co-culture Caco2 cells washed, 
treated with lipids and fresh bacteria treatments and incubated for 2 hrs) treatment was lowest with 8.9-
fold change relative to the control group (Figure 35 and Table 10). Also, there were 3.2 and 5.0 reduction 
in I-FABP expression in LB treated cells in Protocol 1 (overnight co-culture Caco2 cells overlaid and 
incubated with lipids for 2 hrs) and 3 (overnight co-culture Caco2 cells washed and incubated with lipids 
only for 2 hrs) relative to the control. CF treated Protocol 1 demonstrated considerably low expression of I-
FABP, however CF, HIB and FSB treated Protocol 3 lowered I-FABP expression by 1.8, 2.6 and 1.3 compared 
to the control. 
Figure 35. Western blot assay image of I-FABP expression in Caco2 cells 
(CF- Cytoplasmic fraction, FSB- Filtered spent broth, HIB- Heat inactivated bacteria, LB- Live bacteria) 
 
 
TREATMENT CNTRL CF1 CF2 CF3 FSB1 FSB2 FSB3 HIB1 HIB2 HIB3 LB1 LB2 LB3 
GPAT3 REL. 
EXPRESSION* 
9.37 9.19 8.69 9.24 9.52 9.12 8.56 8.14 9.55 10.15 2.05 1.97  4.45 
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I-FABP Expression of Co-Cultured Caco2 Cells Treated According to Protocol 1 
Co-cultured Caco2 cells were overlaid with lipid without washing, after an overnight incubation 
period. There was no significant change in I-FABP expression in Caco2 cells treated with CF, FSB and HIB 
compared to other treatments and the control (Figure 36). However, cells treated with LB induce 
significant reduction in I-FABP expression in cells by 7.92 relative to the control, although there was no 
significance change in I-FABP expression between all treatments. 
 
Figure 36. Effect of Lactobacillus rhamnosus MRS6AN or its extracts on MTP expression in Caco2 cells 
treated according to Protocol 1 (after overnight bacterial treatment, cells were overlaid with lipid mixture 
without washing and incubated for 2 hrs). Each bar represents mean ± SD value of percent fold change 
(n=3). Treatments include CF (cytoplasmic fraction), FSB (filtered spent broth), HIB (heat inactivated 
bacteria), LB (live bacteria) and the control. Bars labelled with different letters are statistically different 
from each other (P≤0.05). 
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I-FABP Expression of Co-Cultured Caco2 Cells Treated According to Protocol 2 
Co-cultured Caco2 cells were washed and treated with lipid and fresh bacteria treatments, after an 
overnight incubation period. Significant reduction in I-FABP expression was observed in Caco2 cells treated 
with LB compared to the control. Other treatments did not induce significant change in I-FABP expression 
in cells relative to the control and there was also no significant variance among all treatments within the 
protocol (Figure 37). 
 
Figure 37. Effect of Lactobacillus rhamnosus MRS6AN or its extracts on MTP expression in Caco2 cells 
treated according to Protocol 2 (after overnight bacterial treatment, cells were washed and treated with 
lipid mixture and fresh bacterial treatments and incubated for 2 hrs). Each bar represents mean ± SD value 
of percent fold change (n=3). Treatments include CF (cytoplasmic fraction), FSB (filtered spent broth), HIB 
(heat inactivated bacteria), LB (live bacteria) and the control. Bars labelled with different letters are 
statistically different from each other (P≤0.05). 
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I-FABP Expression of Co-Cultured Caco2 Cells Treated According to Protocol 3 
There was a significant reduction in I-FABP expression in LB treated Caco2 cells according to 
protocol 3 (overnight co-cultured cells were washed and treated lipids only) compared to the control 
(Figure 38). Other bacterial treatments however did not cause any significant change in I-FABP expression 
of cells relative to the control. 
 
Figure 38. Effect of Lactobacillus rhamnosus MRS6AN or its extracts on MTP expression in Caco2 cells 
treated according to Protocol 3 (after overnight bacterial treatment, cells were washed and treated with 
lipid mixture only and incubated for 2 hrs). Each bar represents mean ± SD value of percent fold change 
(n=3). Treatments include CF (cytoplasmic fraction), FSB (filtered spent broth), HIB (heat inactivated 
bacteria), LB (live bacteria) and the control. Bars labelled with different letters are statistically different 
from each other (P≤0.05). 
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Effect of Bacterial Cytoplasmic Fraction (CF) on I-FABP Expression  
CF treatments across all protocols did not cause significant change in I-FABP expression in Caco2 
cells relative to the control, Furthermore, there was no significant change observed in I-FABP CF treated 
cells across all protocols (Figure 39). 
 
Figure 39: Evaluation of Intestinal-fatty acid binding protein (I-FABP) expression when overnight co-
cultured Caco2 cells were treated with bacteria cytoplasmic fraction (CF). The CF was applied under three 
Protocol (Protocol 1: overnight co-culture Caco2 cells overlaid and incubated with lipids for 2 hrs, Protocol 
2: overnight co-culture Caco2 cells washed, treated with lipids and fresh bacteria treatments and 
incubated for 2 hrs, Protocol 3: overnight co-culture Caco2 cells washed and incubated with lipids only for 
2 hrs). Each bar represents mean fold change relative to the control treatment (n=2 to 3). Bars labelled 
with different letters are statistically different from each other (P≤0.05). 
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Effect of Bacterial Filtered Spent Broth (FSB) on I-FABP Expression  
Effect of bacterial filtered spent broth on I-FABP expression was evaluated across all Protocols, and 
they all demonstrated no significant effect on I-FABP expression level relative to the control. There was no 
significant variance in I-FABP expression across all protocols treated with bacterial filtered spent broth 
(FSB) (Figure 40). 
 
Figure 40: Evaluation of Intestinal-fatty acid binding protein (I-FABP) expression when overnight co-
cultured Caco2 cells were treated with bacteria filtered spent broth (FSB). The FSB was applied under three 
Protocol (Protocol 1: overnight co-culture Caco2 cells overlaid and incubated with lipids for 2 hrs, Protocol 
2: overnight co-culture Caco2 cells washed, treated with lipids and fresh bacteria treatments and 
incubated for 2 hrs, Protocol 3: overnight co-culture Caco2 cells washed and incubated with lipids only for 
2 hrs). Each bar represents mean fold change relative to the control treatment (n=2 to 3). Bars labelled 
with different letters are statistically different from each other (P≤0.05). 
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Effect of Heat Inactivated Bacteria (HIB) on I-FABP Expression 
Expression of I-FABP was not significantly affected by the presence of heat inactivated bacteria 
across all protocols, likewise there was no significant difference in I-FABP expression in all FSB treated 
protocols relative to the control (Figure 41).  
 
Figure 41: Evaluation of Intestinal-fatty acid binding protein (I-FABP) expression when overnight co-
cultured Caco2 cells were treated with heat inactivated bacteria (HIB). The HIB was applied under three 
Protocol (Protocol 1: overnight co-culture Caco2 cells overlaid and incubated with lipids for 2 hrs, Protocol 
2: overnight co-culture Caco2 cells washed, treated with lipids and fresh bacteria treatments and 
incubated for 2 hrs, Protocol 3: overnight co-culture Caco2 cells washed and incubated with lipids only for 
2 hrs). Each bar represents mean fold change relative to the control treatment (n=2 to 3). Bars labelled 
with different letters are statistically different from each other (P≤0.05). 
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Effect of Live L. Rhamnosus (LB) on I-FABP Expression  
Consistent with the significant effect of live MRS6AN on lipid transport associated protein 
expression, I-FABP level was significantly reduced in all protocols treated cells with live bacteria relative to 
the control (Figure 42). with the highest reduction of 7.3 percent fold decrease in Protocol 2 (cells washed 
and treated with lipids and fresh bacterial treatments). There was no significant difference between all LB 
protocol treatments. 
 
Figure 42. Evaluation of Intestinal-fatty acid binding protein (I-FABP) expression when overnight co-
cultured Caco2 cells were treated with live bacteria (LB). The LB was applied under three Protocol 
(Protocol 1: overnight co-culture Caco2 cells overlaid and incubated with lipids for 2 hrs, Protocol 2: 
overnight co-culture Caco2 cells washed, treated with lipids and fresh bacteria treatments and incubated 
for 2 hrs, Protocol 3: overnight co-culture Caco2 cells washed and incubated with lipids only for 2 hrs). 
Each bar represents mean fold change relative to the control treatment (n= 3). Bars labelled with different 
letters are statistically different from each other (P≤0.05). 
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 Table 10: Effect of L. rhamnosus MRS6AN, heat inactivated bacteria, filtered spent broth or its cytoplasmic 
fraction on I-FABP expression in Caco-2 cell. 
 
*Expression values are mean fold change, where n=3, Mean fold change represent protein expression 
relative to the positive control. 
 
Effect of Probiotic Treatment on NPC1L1 Expression 
This transport protein belongs to the sterol transporter family. The expression of NPC1L1 was 
significantly reduced by LB in Protocol 1 (cells overlaid with lipid mixture) by 5.7 percent fold decrease. 
Reduction in expression was also induced in LB treated Protocol 2 and 3 by 4.9 and 3.2 relative to the 
control. Bacterial filtered spent broth (FSB) in Protocol 3 had no significant effect on NPC1L1 expression 
(Figure 43 and Table 11). There was reduction in Protocols 1 and 2 with 3.7 and 2.4-fold decrease in 
expression relative to the control treatment. Heat inactivated bacteria also slightly down-regulated 
NPC1L1 expression in Protocols 1 (cells overlaid with lipids without washing) and Protocol 2 (cells washed 
and treated with lipids and fresh bacteria treatments) by 2.8 and 2.0, with less reduction in Protocol 3 
(cells wash and treated with lipids only) by 1.5-fold decrease. 
 
Figure 43. Western blot assay image of NPC1L1 expression in Caco2 cells 
(CF- Cytoplasmic fraction, FSB- Filtered spent broth, HIB- Heat inactivated bacteria, LB- Live bacteria) 
 
TREATMENT 
 
CNTRL 
 
CF1 
 
CF2 
 
CF3 
 
FSB1 
 
FSB2 
 
FSB3 
 
HIB1 
 
HIB2 
 
HIB3 
 
LB1 
 
LB2 
  
   LB3 
 
I-FABP REL. 
EXPRESSION* 
 
11.75 
 
5.63 
 
10.43 
 
9.28 
 
7.35 
 
8.18 
 
9.83 
 
7.79 
 
10.82 
 
8.23 
 
3.83 
 
3.31 
 
3.23 
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NPC1L1 Expression of Co-Cultured Caco2 Cells Treated According to Protocol 1 
NPC1L1 level of overnight co-cultured Caco2 cells overlaid with lipids without washing was 
determined. There was no significant change in NPC1L1 expression in Caco2 cells treated with CF, FSB and 
HIB compared to other treatments and the control (Figure 44). But LB treatment induce significant 
reduction in NPC1L1 expression in Caco2 cells by 6.36 relative to the control, even though there was no 
significance change in NPC1L1 protein level between all treatments in the protocol group. 
 
Figure 44. Effect of Lactobacillus rhamnosus MRS6AN or its extracts on MTP expression in Caco2 cells 
treated according to Protocol 1 (after overnight bacterial treatment, cells were overlaid with lipid mixture 
without washing and incubated for 2 hrs). Each bar represents mean ± SD value of percent fold change 
(n=3). Treatments include CF (cytoplasmic fraction), FSB (filtered spent broth), HIB (heat inactivated 
bacteria), LB (live bacteria) and the control. Bars labelled with different letters are statistically different 
from each other (P≤0.05). 
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NPC1L1 Expression of Co-Cultured Caco2 Cells Treated According to Protocol 2 
Overnight co-cultured Caco2 cells treated with LB showed significant reduction in NPC1L1 
expression compared with CF, FSB and HIB treated cells (Figure 45). The expression level of NPC1L1 LB 
treated cells was also significantly reduced by 5.88 relative to the control, although there was no 
significance change in NPC1L1 expression between treatments with CF, FSB and HIB. 
 
Figure 45. Effect of Lactobacillus rhamnosus MRS6AN or its extracts on MTP expression in Caco2 cells 
treated according to Protocol 2 (after overnight bacterial treatment, cells were washed and treated with 
lipid mixture and fresh bacterial treatments and incubated for 2 hrs). Each bar represents mean ± SD value 
of percent fold change (n=3). Treatments include CF (cytoplasmic fraction), FSB (filtered spent broth), HIB 
(heat inactivated bacteria), LB (live bacteria) and the control. Bars labelled with different letters are 
statistically different from each other (P≤0.05). 
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NPC1L1 Expression of Co-Cultured Caco2 Cells Treated According to Protocol 3 
Caco2 cells treated according to protocol 3 (overnight co-cultured cells were washed and treated 
lipids only) showed significant reduction in NPC1L1 protein level in Caco2 cells treated with LB compared 
to CF, FSB and HIB treated cells by 5.4, 5.7 and 5.1 respectively, similarly significant decrease in NPC1L1 
protein level was observed in LB treated cells by 5.88 compared with the control (Figure 46). There was no 
significant difference in NPC1L1 expression between other bacteria treatments. 
 
Figure 46. Effect of Lactobacillus rhamnosus MRS6AN or its extracts on MTP expression in Caco2 cells 
treated according to Protocol 3 (after overnight bacterial treatment, cells were washed and treated with 
lipid mixture only and incubated for 2 hrs). Each bar represents mean ± SD value of percent fold change 
(n=3). Treatments include CF (cytoplasmic fraction), FSB (filtered spent broth), HIB (heat inactivated 
bacteria), LB (live bacteria) and the control. Bars labelled with different letters are statistically different 
from each other (P≤0.05). 
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Effect of Bacterial Cytoplasmic Fraction (CF) on NPC1L1 Expression  
Expression of sterol transporter NPC1L1 was not significantly affected in Caco2 cells between 
Protocols 1 (cells overlaid with lipids without washing) and Protocol 2 (cells washed and treated with lipids 
and fresh bacteria treatments) and Protocol 3 (cells washed and treated with lipids only) and relative to the 
control treatment (Figure 47).   
 
Figure 47. Evaluation of the effect of bacteria cell extract (CF) on NPC1L1 expression in Caco2 cells across 
Protocol treatments. The CF was applied under three Protocol (Protocol 1: overnight co-culture Caco2 cells 
overlaid and incubated with lipids for 2 hrs, Protocol 2: overnight co-culture Caco2 cells washed, treated 
with lipids and fresh bacteria treatments and incubated for 2 hrs, Protocol 3: overnight co-culture Caco2 
cells washed and incubated with lipids only for 2 hrs). Each bar represents mean fold change relative to the 
control treatment (n=2 to 3). Bars labelled with different letters are statistically different from each other 
(P≤0.05). 
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Effect of Bacterial Filtered Spent Broth (FSB) on NPC1L1 Expression  
Bacterial filtered spent broth induced a significant reduction in NPC1L1 expression in cells from 
Protocol 1 (cells overlaid with lipids without washing) and Protocol 2 (overnight co-culture Caco2 cells 
washed, treated with lipids and fresh bacteria treatments) relative to the control treatment (Figure 48). 
There was significant difference between FSB treated cells according to protocol 1 and Protocol 3 
(overnight co-culture Caco2 cells washed and treated with lipids only). Caco2 cells treated according to 
protocol 3 showed no significant difference in NPC1L1 expression compared to protocol 2 and control 
treatment. 
 
Figure 48. Evaluation of the effect of bacteria filtered spent broth (FSB) on NPC1L1 expression in Caco2 
cells across Protocol treatments. The FSB was applied under three Protocol (Protocol 1: overnight co-
culture Caco2 cells overlaid and incubated with lipids for 2 hrs, Protocol 2: overnight co-culture Caco2 cells 
washed, treated with lipids and fresh bacteria treatments and incubated for 2 hrs, Protocol 3: overnight 
co-culture Caco2 cells washed and incubated with lipids only for 2 hrs). Each bar represents mean fold 
change relative to the control treatment (n= 3). Bars labelled with different letters are statistically different 
from each other (P≤0.05). 
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Effect of Heat Inactivated Bacteria (HIB) on NPC1L1 Expression  
NPC1L1 expression level although showed slight reduction in HIB treated Protocol 1 (overnight co-
culture Caco2 cells overlaid and incubated with lipids for 2 hrs.), it was not significantly different form 
other protocols and when compared with the control treatment (Figure 49). Likewise, heat inactivated 
bacteria (HIB) had no significant effect on the expression of NPC1L1 between all the protocols. 
 
Figure 49. Evaluation of the effect of heat inactivated bacteria (HIB) on NPC1L1 expression in Caco2 cells 
across Protocol treatments. The HIB was applied under three Protocol (Protocol 1: overnight co-culture 
Caco2 cells overlaid and incubated with lipids for 2 hrs, Protocol 2: overnight co-culture Caco2 cells 
washed, treated with lipids and fresh bacteria treatments and incubated for 2 hrs, Protocol 3: overnight 
co-culture Caco2 cells washed and incubated with lipids only for 2 hrs) Each bar represents mean fold 
change relative to the control treatment (n= 3). Bars labelled with different letters are statistically different 
from each other (P≤0.05). 
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Effect of Live Bacteria (LB) on NPC1L1 Expression.  
 
Live Lactobacillus rhamnosus (LB) significantly reduced the expression of NPC1L1 in all the 
treatment Protocols compared to the control treatment (Figure 50). There was however no considerable 
difference in NPC1L1 protein level between all the protocol treatments. 
 
Figure 50. Evaluation of the effect of bacteria cell extract on NPC1L1 expression in Caco2 cells across 
Protocol treatments. The LB was applied under three Protocol (Protocol 1: overnight co-culture Caco2 cells 
overlaid and incubated with lipids for 2 hrs., Protocol 2: overnight co-culture Caco2 cells washed, treated 
with lipids and fresh bacteria treatments and incubated for 2 hrs., Protocol 3: overnight co-culture Caco2 
cells washed and incubated with lipids only for 2 hrs.). Each bar represents mean fold change relative to 
the control treatment (n=2 to 3). Bars labelled with different letters are statistically different from each 
other (P≤0.05). 
 
 
101 
 
Table 11. Effect of L. rhamnosus MRS6AN, heat inactivated bacteria, filtered spent broth or its cytoplasmic 
fraction on NPC1L1 expression in Caco-2 cell. 
 
 
TREATMENT 
 
CNTRL 
 
CF1 
 
CF2 
 
CF3 
 
FSB1 
 
FSB2 
 
FSB3  
 
HIB1 
 
HIB2 
 
HIB3 
 
LB1 
 
LB2 
  
LB3 
 
NPC1L1 REL. 
EXPRESSION* 
 
10.32 
 
6.99 
 
7.71 
 
9.82 
 
7.73 
 
8.10 
 
10.15 
 
7.76 
 
9.01 
 
9.58 
 
3.96 
 
4.43 
 
4.44 
*Expression values are mean fold change, where n=3, Mean fold change represent protein expression 
relative to the positive control. 
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CHAPTER 4 
DISCUSSION 
This study was carried out in response to the prevailing level of diet induced obesity, hepatic 
associated dysfunctions, coronary heart disease and insulin resistance induced diabetes. The main purpose 
of this study is to develop a feasible alternative therapy using probiotic Lactobacillus rhamnosus to reduce 
the prevalence of health abnormalities such as obesity, type II diabetes and hyperlipidemia (Kang et al. 
2013). The fact that not only Lactobacillus sp. can deconjugate bile acid (for example bile acids frequently 
are conjugated to sulfate or glucoronate to allow easier excretion) suggest that other members of the 
intestinal microbiota may also influence intestinal lipid profile (Shimada K et al. 1969). Several research 
studies have validated the intestinal lipid modulation effect of the genus lactobacilli. Reduction in total 
cellular lipid content and intracellular triglyceride level of cells was shown in cells treated with lipids 
alongside live bacteria bacterial, cytoplasmic fraction or its filtered spent broth. The pro-active influence of 
live Lactobacillus sp. cannot be overemphasized, although significant reduction in total cellular lipid 
content had been shown to influenced by probiotic isolates (Kang et al. 2013). Disparities may exist based 
on strains and genera of probiotics involved (Santos et al. 2013). Greany et al. (2004) have shown that daily 
administration of L. plantarum strain dosage was enough to significantly reduce cholesterol in Sprague 
Dawley rats, but L. acidophilus and Bifidobacterium longnum strains could not significantly induce change 
in Sprague Dawley rat dietary lipid. Zhang and his colleagues in 2012 showed that a strain of Lactobacillus 
plantarum NR74 induced more reduction in cellular cholesterol in Caco2 cells compared to LXR agonist, a 
nuclear receptor responsible for control of transcription factors of genes liable for uptake, transport and 
excretion of dietary cholesterol (Zhang et al. 2013).  
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Reduction in the level of free fatty acids (FFA) in gut had been shown to be induced by a L. rhamnosus 
strain, but this process was facilitated when strain of L. acidophilus was mutagenized by N-methyl-N-nitro-
N-nitroso guanidine (NTG), a palmitate absorption stimulant that causes the bacteria to readily absorb free 
fatty acids (FFA) (Chung et al. 2016). This indicates a feasible way to engineer probiotics towards inhibition 
of diet induced obesity (Chung et al. 2016).  
There were no significant changes in the level of total cellular lipid content (TL) of Caco2 cells in all 
treatment protocols, this could indicate that the TL content of treated cell accounts for total lipids 
containing within the cell and extracellular lipid contents of the cell membrane.  
It has further been reported that oral administration of probiotic bacteria could reduce the level of 
blood triglycerides by assimilation of dietary lipid by bacteria, inhibition of hepatic cholesterol and 
triglyceride by SCFA and deconjugation of bile acid by secretion of hydrolase enzyme (Rastislav et al. 2013).  
Intracellular triglyceride level reduction by L. rhamnosus MRS6AN in the present study could be due to 
such mechanisms. L. plantarum has been reported to induce significant reduction in serum triglyceride 
compared to other probiotic species after an oral probiotic administration (Rastislav et al. 2013). Caco2 
cells treated with live bacteria (LB) according to protocol 1 (overnight co-cultured cells were overlaid 
directly with lipids without washing) and 2 (overnight co-cultured cells were washed and treated with 
lipids and fresh bacteria treatments) demonstrated significantly low level of intracellular triglyceride, these 
results indicate that the presence of live bacteria might be needed to elicit any change intracellular TG 
level. Although these two protocols presented significant difference in intracellular TG content, however, 
Caco2 cells treated according to protocol 1 demonstrated lower level of intracellular TG compared to 
protocol 2 treatment. This could indicate that probiotic flora need to colonize the gastrointestinal tract and 
their presence might serve as a bio-sequestrant thereby reducing the quantity of lipids absorbed by 
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enterocytes (Chung et al. 2016).  This finding suggests that the presence of live bacteria might be needed 
for lipid uptake to be regulated.  
Reduction in triglyceride level by live probiotics might also be because of the instigation of lipase 
activities in the lumen during triglyceride assembly which decreases lipid absorption and alternatively 
enhances lipid catabolism and antioxidant activities (Harisa et al. 2009).  
Facinelli et al. (2015) observed reduction in triglyceride level in zebrafish model treated orally with 
Lactobacillus rhamnosus. This was suggested to be due to expression of genes involved in TG metabolism 
and lipolysis (Huang and Zheng 2010). During lipid uptake in the intestine, there are 2 main routes through 
which triacylglycerol is synthesized: monoacylglycerol and glycerol-3-phosphate. Glycerol-3-phosphate 
pathway is the primary route which is catalyzed by a GPAT3, a member of the GPAT family (Khatun 2015). 
In the present study, significant reduction in the expression of GPAT3 was observed in live bacteria treated 
cell across all protocol treatments. Because triglyceride level was inhibited by live bacteria, reduction of 
GPAT3 enzymatic activity might be due to the reduced uptake of dietary triglyceride by Caco2 cells. 
Enterocytes transiently store dietary triglycerides as cytosolic lipid droplet as they are being 
absorbed (Zhu 2009). GPAT3 enzymes are overly expressed at the apical region of enterocytes during this 
process. Triglyceride level was not affected in fasted GPAT3 knock-out mice and the wild type. However, 
fed wild type mice exhibited reduced triglyceride levels compared to the knock-out (Khatun 2015). Result 
in the present study demonstrated reduced triglyceride levels with a corresponding decrease in GPAT3 
expression. This could indicate that activation and expression of GPAT3 might be associated with influx of 
triglyceride into enterocytes. A study that was carried out on the possible mechanism behind the 
reduction in ER stress during lipid uptake after administration of dosage of L. rhamnosus GG revealed that 
GPAT3 enzyme alongside other lipid metabolism associated protein were downregulated in skeletal 
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muscles of LGG fed diabetic mice resulting in reduced lipotoxicity (Park et al. 2015). Apart from probiotics, 
dietary polyphenol had also been shown to reduce GPAT3 mRNA level in which increases fatty acid 
oxidation and reduced FA esterification (Baboota et al. 2013).  
In the present study, there was a reduction in MTP expression in Caco2 cells treated with live 
bacteria across all treatment Protocols. It has been reported that ablation or “knock-out” of intestinal MTP 
increases intestinal lipid absorption and reduces plasma lipoproteins (Iqbal et al. 2014). The present study 
investigates effects of probiotic treatment on TG accumulation, MTP expression might not really be 
affected since it is responsible for assembly and transfer of lipoprotein as chylomicrons for excretion and 
not triglyceride accumulation (Jamil et al. 1995) and (Iqbal et al. 2014). Iqbal et al. (2014) stressed that 
deletion of intestinal MTP led to a decrease in total plasma triglyceride and cholesterol level. A reduction 
in MTP expression in the present study was probably triggered by the reduction in lipid absorption by the 
Caco2 cells.   
The high expression level of intestinal fatty acid binding protein (I-FABP) in the enterocytic cytosol 
is responsible for 95 % of lipids that are taken up by enterocytes (Storch et al. 2010). This cytosolic water-
soluble protein readily binds fatty acid with high affinity thereby facilitating lipid uptake (Richieri et al. 
1994) and (Richieri et al. 2000). The relative expression of I-FABP was significantly reduced in the present 
study, in cells treated with live bacteria (LB) but no considerable change in cells treated with heat 
inactivated bacteria (HIB), filtered spent broth (FSB) and cytoplasmic fraction (CF). This suggests that 
inhibitory activity of L. rhamnosus MRS6AN might require the presence of the whole bacteria. Strains of L. 
rhamnosus had been reported to inhibit atherosclerosis by reduction in I-FABP expression with subsequent 
reduced intestinal lipid profile of high fat diet fed mice (Chan et al. 2016). They have also been shown to 
help in the regulation of unbounded fatty acid by binding excess free fatty acid (Atshaves et al. 2010). This 
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supports the idea that its expression is upregulated during high fat diet uptake (Bass 1990). Evaluation of 
the prophylactic effect of L. acidophilus on necrotizing enterocolitis (NEC) and its role in I-FABP activation 
in a study carried out by Francis and his team in 2014 showed that FABP was reduced when NEC inflamed 
intestine was augmented with L. acidophilus. 
The sterol transporter NPC1L1 was downregulated in the presence of live Lactobacillus rhamnosus. 
Caco2 treated with bacterial cytoplasmic or its filtered spent broth also showed no significant change in 
NPC1L1 expression, heat inactivated bacteria did not alter NPC1L1 expression. Huang and Zheng’s study in 
2010 on elucidating the possible underlying mechanism behind NPC1L1 inhibition by probiotic L. 
acidophilus during bacteria-cell interaction reported that heat inactivated L. acidophilus did not 
significantly reduce NPC1L1 expression. They further stressed that bacteria culture supernatant caused 
reduction in NPC1L1 expression (Huang and Zheng 2010), these findings are however consistent with our 
results. Although there was no significant change in NPC1L1 expression in FSB treated in all protocols 
relative to control, nevertheless, there was a significant decrease in NPC1L1 expression in FSB treated cell 
according to protocol 1 (overnight co-cultured cells overlaid with lipids without washing) compared to 
protocol 3 (overnight co-cultured cells washed and treated with lipids only). 
Gorenjak et al. in 2014 revealed a contrary result to that of Huang and Zheng when he stated that 
Lactobacillus GG did not downregulate NPC1L1 expression in Human intestinal epithelia cell line (HIEC), 
while Huang and Zheng reported that L. rhamnosus GG significantly reduced NPC1L1 in Caco-2 cell line. 
Gorenjak suggested that the possibilities in the different results might be attributable to different cell lines 
used and discrepancies in the qPCR layout. Stancu et al (2014) concluded that administration of probiotic 
mix of Lactobacillus acidophilus and Bifidobacterium animalis led to an overall decrease in expression on 
NPC1L1 and MTP in the gut with a corresponding decrease in plasma lipid and total cholesterol. Mice 
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expressing loss of intestinal NPC1L1 have also been shown to display reduced intestinal cholesterol 
absorption and likely to be less prone to hypercholesteremia (Eddy and Masuku 2014). This finding was 
corroborated by Lim et al. in 2016 when he concluded that prolonged exposure of HT29 cells treated with 
probiotics led to downregulation of NPC1L1. 
In conclusion, intracellular triglyceride level (TG) of Caco2 cells was significantly reduced by live 
Lactobacillus rhamnosus (LB) compared with other bacterial products indicating that presence and 
interaction with the whole Lactobacillus rhamnosus might be required to inhibit lipid absorption. MTP 
expression in Caco2 cells was minimally reduced in live L. rhamnosus (LB) treated Caco2 cells. However, 
the expression level GPAT3, I-FABP and NPC1L1 was reduced in Caco2 cells treated with live bacteria. 
Lactobacillus rhamnosus MRS6AN may reduce lipid uptake and accumulation perhaps via modulation of 
GPAT3, I-FABP and NPC1L1. 
 
Future Research 
Future study designed to investigate the effect of probiotics on mRNA level of various genes 
involved in G3P pathway in lipid absorption is highly recommended. This is because with respect to the 
results obtained from this study, there might be transcriptional regulation of some of the genes at mRNA 
level. It is also essential to determine the specific receptor on the bacterial cell responsible for interaction 
with Caco2 cells during lipid absorption. This study focused on effect of probiotics on lipid uptake and 
accumulation in Caco2 cells, subsequent study can possibly look into their effect on secretion of 
triacylglycerol (TAG).  These might help in designing therapeutic and novel drugs that will help in reducing 
intestinal absorption and accumulation of dietary lipids. This study should also be carried out in mice 
models fed with high fat diet alongside with probiotics and investigate its effect on intestinal G3P pathway 
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expression, this might help in establishing the effect of probiotics on GPAT3 mediated pathway in lipid 
uptake.  
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